License and Support Agreement, dated as of May 6, 2016, by and between Epic Systems Corporation and AHS Management Company, Inc
Exhibit 10.17
1979 Milky Way, Verona, WI 53593
LICENSE AND
SUPPORT AGREEMENT
This License and Support Agreement (the Agreement) is made between Epic Systems Corporation, which is located at 1979 Milky Way, Verona, Wisconsin 53593 (Epic); and AHS Management Company, Inc., a company having its principal place of business at One Burton Hills Boulevard, Suite 250, Nashville, Tennessee 37215(You).
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
- SIGNATURE PAGE FOLLOWS -
36
THIS AGREEMENT HAS BEEN ENTERED INTO AS OF THE EXECUTION DATE INDICATED BY YOUR SIGNATURE BELOW.
[***]
37
APPENDIX A
DEFINITIONS
1
2
3
4
5
6
7
8
List of Exhibits
EXHIBIT | DESCRIPTION | |
1(a) | List of All Licensed Program Property, Additional Billing Information, and Applicable Limitations | |
1(b) | Standard Interfaces | |
1(c) | [***] | |
1(d) | [***] | |
1(e) | [***] | |
2(a) | Preliminary Implementation Sequence | |
2(b) | Sample Implementation Schedule | |
3(a) | Budget Allocation Form | |
3(b) | Change Order Form | |
3(c) | Third Party Tools Order | |
4 | Epics Current Standard Hourly Rates | |
5 | Business Associate Exhibit | |
6 | Definition of Volume | |
7 | Epics Support Policies | |
8 | Epic Error Correction Services | |
9 | Hardware Configuration | |
10 | Good Install Program | |
11 | Sample Reports | |
12 | 2014 Certification Notification | |
13 | ECL Online Agreement | |
14 | Epic Travel Policy | |
15 | Litigation | |
Addendum | Care Everywhere Addendum | |
Addendum | ACC-NCDR® Registry Communication Module Addendum | |
Addendum | InterSystems Addendum: Terms of Intersystems Sublicense | |
Addendum | SQL Addendum: Terms of KB Systems KB_SQL Sublicense | |
Addendum | Business Objects Addendum | |
Addendum | CPT Addendum | |
Addendum | Dr. Schmitt Pediatric Content Addendum | |
Addendum | Dr. Thompson Adult Medical Content Addendum |
Addendum | Diagnostic Data Addendum | |
Addendum | BI-RADS Atlas Addendum | |
Addendum | Illustration Addendum | |
Addendum | Miscellaneous Assessment Tool Collection Addendum | |
Addendum | Academy of Nutrition and Dietetics Addendum |
2
Exhibit 1(a)
Enterprise Software
Epic Program Property: | Initial Monthly Maintenance Fee1: | Comments: | ||
EpicCare Inpatient Clinical System [***] | [***] | [***] | ||
EpicCare Ambulatory Electronic Health Record [***] | [***] | [***] | ||
Beaker Laboratory [***] | [***] | [***] | ||
Beacon Oncology | [***] | [***] | ||
Cupid Cardiology | [***] | [***] | ||
EpicCare Home Health and Hospice | [***] | [***] | ||
EpicCare Orthopaedics | [***] | [***] | ||
Kaleidoscope Ophthalmology | [***] | [***] | ||
OpTime Operating Room Management System [***] | [***] | [***] | ||
Phoenix Transplant [***] | [***] | [***] | ||
Radiant Radiology | [***] | [***] | ||
Stork Obstetrics | [***] | [***] | ||
Willow Ambulatory Pharmacy [***] | [***] | [***] | ||
Wisdom General Dentistry | [***] | [***] | ||
Resolute Hospital Billing and Patient Accounting [***] | [***] | [***] | ||
Resolute Professional Billing and Patient Accounting [***] | [***] | [***] | ||
Tapestry Managed Care Administration for Providers [***] | [***] | [***] | ||
Cadence Enterprise Scheduling [***] | [***] | [***] | ||
Grand Central ADT and Prelude Inpatient Registration4 | [***] | [***] | ||
Nurse Triage | [***] | [***] | ||
Call Management / Customer Relationship Management | [***] | [***] | ||
Health Information Management Chart Tracking | [***] | [***] |
1
Epic Program Property: | Initial Monthly Maintenance Fee1: | Comments: | ||
EpicCare Link | [***] | [***] | ||
Blood Product Administration Module [***] | [***] | [***] | ||
Remote Monitoring6 | [***] | [***] | ||
Cogito Enterprise Intelligence [***] | [***] | [***] | ||
Interfaces8 | [***] | [***] | ||
Bridges EDI Developers License9 | [***] | [***] | ||
Charge Router10 | [***] | [***] | ||
Identity Embedded Master Person Index11 | [***] | [***] | ||
Patient Abstractor12,13 | [***] | [***] | ||
Pulse13 | [***] | [***] | ||
System Pulse13 | [***] | [***] |
Limitations and Notes
Each Item of Program Property is licensed solely for use in accordance with the Documentation Manuals with the other Items of Program Property included in this Exhibit 1(a) at the Licensed Volume specified for the Program Property.
If Your Licensed Volume increases or additional Epic software is licensed, additional fees will apply.
No terms or conditions in any pricing proposal or disclosure that is not a part of the Agreement will amend this Agreement or otherwise constitute an agreement between the parties.
Meaningful Use certification guidelines require the following additional details about certification status:
http://www.epic.com/Docs/MUCertification.pdf
[***]
[***]
[***] | | [***] | | |
[***] | [***] | |||
|
| |||
Total Term Payment Amount: | $ | 19,631,336 | ||
[***] | [***] | |||
[***] | [***] |
[***]
2
[***]
3
[***]
4
Other Program Property
Program Property | License Fee (US $) | Initial Monthly Mtnc. Fee (US $) | Comments/Licensed Volumes1 | |||
Star Data Warehouse | [***] | [***]
[***] | ||||
Healthy Planet [***] | [***] | [***] |
5
Program Property | License Fee (US $) | Initial Monthly Mtnc. Fee (US $) | Comments/Licensed Volumes1 | |||
MyChart Shared Patient Record | [***] | [***] | ||||
MyChart Bedside | [***] | [***] | ||||
Haiku Server | [***] | [***] |
6
Program Property | License Fee (US $) | Initial Monthly Mtnc. Fee (US $) | Comments/Licensed Volumes1 | |||
Push Notifications | [***] | [***]
| ||||
Welcome Patient Kiosk | [***] | [***]
| ||||
Care Everywhere | [***] | [***] | ||||
ACC-NCDR® Registry Communication Module | [***] | [***] |
Limitations and Notes
Each Item of Program Property is licensed solely for use in accordance with the Documentation Manuals with the other Items of Program Property included in this Exhibit 1(a).
[***]
7
[***]
8
Additional Billing Information Description (Third Party Software and Data; not Program Property) | License Fee1 (US $) | Initial Monthly Mtnc. Fees1,2 (US $) | Comments/Licensed Levels | |||
InterSystems Caché Single Server, Platform Specific with Shadow | [***] | [***] | [***] | |||
InterSystems Caché Small Non-Production License | [***] | [***] | [***] | |||
KB Systems SQL | [***] | [***] | [***] | |||
PKWARE SecureZIP | [***] | [***] | [***] | |||
Business Objects Enterprise Professional / Crystal Report Professional | [***] | [***] | [***] | |||
CPT Code License iSWTD only | [***] | [***] | ||||
Dr. Schmitts Pediatric Telephone Triage Protocols Office Hours Version3,4 | [***] | [***] |
9
Additional Billing Information Description (Third Party Software and Data; not Program Property) | License Fee1 (US $) | Initial Monthly Mtnc. Fees1,2 (US $) | Comments/Licensed Levels | |||
Dr. Schmitts Pediatric Telephone Triage Algorithms After Hours Version3,4 | [***] | [***] | ||||
Dr. Thompsons Adult Telephone Triage Protocols Office Hours Version 3,4 | [***] | [***] | ||||
Dr. Thompsons Adult Telephone Triage Algorithms After Hours Version 3,4 | [***] | [***] | ||||
Diagnostic Data | [***] | [***] | [***] | |||
BI-RADS® ATLAS | [***] | [***] | [***] | |||
Images from the Sourcebook of Medical Illustration | [***] | [***] | [***] | |||
Miscellaneous Assessment Tools Collection | [***] | [***] | [***] | |||
Academy of Nutrition and Dietetics Terminology | [***] | [***] | [***] |
Limitations and Notes
Licensed levels are designated above in Comments/Licensed Levels column. Each item of Third Party Software and Data is licensed solely for use at the specified licensed levels with the Items of Program Property included in this Exhibit 1(a) at the Licensed Volume specified for the Program Property.
Additional fees will apply if license levels or Licensed Volumes increase or if applications are added.
1 | Prices for Third Party Software and Data are as of April 21, 2016, and are subject to change if delivery does not occur within 60 days of such date. |
[***]
10
[***]
11
Certain Other 3rd Party Software and/or Data1 (not Program Property ) (not Third Party Software and Data) | License Fee (US $) | Initial Monthly Mtnc. (US $) | Comments/Licensed Levels2 | |||
Health Language | [***] | [***] | ||||
Experian HealthLCD/NCD | [***] | [***] | ||||
Experian Health - Correct Coding Initiative Rules | [***] | [***] | ||||
ACR Select | [***] | [***] |
Limitations and Notes
Licensed levels are designated above in Comments/Licensed Levels column and/or in and subject to the separate agreements. This Certain Other 3rd Party Software and/or Data is licensed solely for use at the specified licensed levels with the Items of Program Property included in this Exhibit 1(a) at the Licensed Volume specified for the Program Property.
Additional fees will apply if license levels or Licensed Volumes increase or if applications are added.
1 | This Certain Other 3rd Party Software and/or Data is not sublicensed to You by Epic. The amounts shown here are only estimates of prices as of April 21, 2016. You must sign a license agreement directly with the applicable third party vendor. Epic will provide You with a copy of the applicable agreements. |
[***]
12
[***]
13
[***]
14
Exhibit 1(b)
Standard Interfaces
The tables below list Epics unique standard interfaces as of February 15, 2016. An updated list of currently available standard interfaces can be provided upon request. Implementation, customization and other hourly services related to interfaces will be billed at Epics then-current hourly rates.
# | Epic Standard Interfaces | Available Formats | ||
1 | Incoming Patient Administration | HL7 v2 | ||
2 | Outgoing Patient Administration | HL7 v2 | ||
3 | Outgoing Syndromic Data | HL7 v2 | ||
4 | Incoming Financial Transactions1 | HL7 v2 | ||
5 | Outgoing Financial Transactions | HL7 v2 | ||
6 | Incoming Appointment Scheduling | HL7 v2 | ||
7 | Outgoing Appointment Scheduling | HL7 v2 | ||
8 | Incoming Schedule Query | HL7 v2 | ||
9 | Incoming Ancillary Results and Orders | HL7 v2 | ||
10 | Outgoing Ancillary Orders | HL7 v2 | ||
11 | Outgoing Imaging Results and Orders | HL7 v2 | ||
12 | Outgoing Dietary Orders | HL7 v2 | ||
13 | Outgoing Clinical Results | HL7 v2 | ||
14 | Incoming Transcriptions | HL7 v2 | ||
15 | Incoming Scanned Document Link | HL7 v2 | ||
16 | Outgoing Scanned Document Link Maintenance | HL7 v2 | ||
17 | Incoming Deficiency Tracking | HL7 v2 | ||
18 | Incoming EOB Scanning | HL7 v2 | ||
19 | Outgoing Documentation | HL7 v2 | ||
20 | Outgoing Medication Orders to Retail Pharmacies2 | NCPDP v8.1; NCPDP v10.6 | ||
21 | Incoming Refill Requests from Retail Pharmacies2 | NCPDP v8.1; NCPDP v10.6 | ||
22 | Outgoing Pharmacy Benefit Eligibility Query270/2712,3 | X12 | ||
23 | Outgoing Medication Dispense History Query2 | NCPDP v8.1; NCPDP v10.6 | ||
24 | Outgoing Prescription Prior Authorization Request and Response | NCPDP ###-###-#### | ||
25 | Incoming Medication Dispenses from ADS to Willow Inpatient | HL7 v2 | ||
26 | Incoming Load/Unload from ADS to Willow Inpatient | HL7 v2 | ||
27 | Outgoing Verified Medication Orders from Willow Inpatient | HL7 v2 | ||
28 | Outgoing Formulary Information to ADS from Willow Inpatient | HL7 v2 | ||
29 | Outgoing Medication Stock Transfer Request and Response | HL7 v2 | ||
30 | Incoming Medication Orders to Willow Ambulatory4 | NCPDP v10.6 | ||
31 | Outgoing Refill Requests from Willow Ambulatory4 | NCPDP v10.6 | ||
32 | Incoming Fill Status from Automated Fill System to Willow Ambulatory | HL7 v2 | ||
33 | Outgoing Fills to Automated Fill System from Willow Ambulatory | HL7 v2 | ||
34 | Outgoing Pharmacy Benefit Claim Adjudication Query | NCPDP v5.1; NCPDP vD.0 | ||
35 | Incoming Medication Orders to EpicCare Ambulatory | HL7 v2 | ||
36 | Outgoing Medication Orders from EpicCare Ambulatory | HL7 v2 | ||
37 | Incoming Medication Administration Notification5 | HL7 v2 | ||
38 | Outgoing Medication Administration Notification5 | HL7 v2 | ||
39 | Incoming Device Data | HL7 v2 | ||
40 | Incoming Injectable Medication Documentation6 | HL7 v2 | ||
41 | Incoming Clinical Documentation Flowsheet Data | HL7 v2 | ||
42 | Outgoing Clinical Documentation Flowsheet Data | HL7 v2 | ||
43 | Incoming Clinical Observations | HL7 v2 |
Page 1 of 4
# | Epic Standard Interfaces (Continued) | Available Formats | ||
44 | Incoming Procedure Log Data | HL7 v2 | ||
45 | Outgoing Procedure Log Data | XML | ||
46 | Incoming Vaccination Administration7 | HL7 v2 | ||
47 | Outgoing Vaccination Administration7 | HL7 v2 | ||
48 | Outgoing Vaccination History Query7 | HL7 v2 | ||
49 | Incoming Materials Management | HL7 v2 | ||
50 | Outgoing Inventory Depletion | HL7 v2 | ||
51 | Incoming Surgical Instrument Data | HL7 v2 | ||
52 | Incoming Surgical Cart Tracking | HL7 v2 | ||
53 | Incoming Procedural Supply Usage | HL7 v2 | ||
54 | Incoming Surgical Case Tracking | HL7 v2 | ||
55 | Outgoing Surgical Case Scheduling | HL7 v2 | ||
56 | Incoming Results from Lab Instruments | HL7 v2 | ||
57 | Outgoing Orders to Lab Instruments | HL7 v2 | ||
58 | Incoming Orders from CPOE Systems | HL7 v2 | ||
59 | Outgoing Lab Results and Orders to External Providers | HL7 v2 | ||
60 | Outgoing Cancer Reporting8 | HL7 CDA | ||
61 | Outgoing IRIS Ophthalmology Encounter Summary9 | Custom | ||
62 | Outgoing Dialysis Update to CMS | XML | ||
63 | Incoming Provider Information | HL7 v2; Web Service | ||
64 | Outgoing Provider Information | HL7 v2 | ||
65 | Incoming Personnel Management | HL7 v2; Web Service | ||
66 | Incoming Location and Department Information | HL7 v2 | ||
67 | Incoming Problem List | HL7 v2 | ||
68 | Outgoing Problem List | HL7 v2 | ||
69 | Incoming Real-Time Location System Updates (bidirectional) | HL7 v3 | ||
70 | Research Study Management and Enrollment (bidirectional) | HL7 v3 (RPE, CRPC profiles) | ||
71 | Outgoing Clinical Trials Forms Submission | HL7 v3 (RFD profile) | ||
72 | Outgoing Birth Registry Reporting IHE BFDR Profile | HL7 v3 (RFD profile or Direct) | ||
73 | Incoming MPI and Demographics Query10 | HL7 v2 | ||
74 | Outgoing MPI and Demographics Query | HL7 v2 | ||
75 | Incoming IVR Account and Demographics Query | HL7 v2 | ||
76 | Incoming Coding Query and Response | HL7 v2 | ||
77 | Incoming Patient Education | HL7 v2 | ||
78 | Outgoing Patient Education | HL7 v2 | ||
79 | Incoming Family Medical History | XML | ||
80 | Outgoing Family Medical History | XML | ||
81 | Incoming Flowsheet Data from Home Device Data Concentrator | HL7 v2 | ||
82 | Outgoing Registration to Home Device Data Concentrator | HL7 v2 | ||
83 | Outgoing Referral Notification | HL7 v2 | ||
84 | Coding (bidirectional)11 | HL7 v2 | ||
85 | Data Exchange with 3M Core Grouping Software12 | Custom | ||
86 | Outgoing Claim Scrubber Query | HL7 v2; Custom (OptumInsight) | ||
87 | Outgoing Address Verification Query | HL7 v2 | ||
88 | Outgoing Eligibility Verification Query270/271 (bidirectional)3,13 | X12 | ||
89 | Outgoing Claim Status Request276/277 (bidirectional)3,13 | X12 |
Page 2 of 4
# | Epic Standard Interfaces (Continued) | Available Formats | ||
90 | Outgoing Health Care Services Authorization Query278/278 (bidirectional)3,13 | X12 | ||
91 | Outgoing Admission Notification278/278 (bidirectional)3,13 | X12 | ||
92 | Tapestry Incoming Health Care Services Authorization Notification278/278 | X12 | ||
(bidirectional)3,13 | ||||
93 | Tapestry Outgoing Health Care Services Authorization Notification278/278 | X12 | ||
(bidirectional)3,13 | ||||
94 | Tapestry Incoming Health Care Services Review Request (Health Plan)278/278 | X12 | ||
(bidirectional)3,13 | ||||
95 | Tapestry Outgoing Health Care Services Unsolicited278/2783,13 | X12 | ||
96 | Tapestry Incoming Additional Information for Health Care Services Authorization | X12 | ||
Notification275/275 (bidirectional)3,13 | ||||
97 | Tapestry Outgoing Additional Information for Health Care Services Authorization | X12 | ||
Notification275/275 (bidirectional)3,13 | ||||
98 | Tapestry Incoming Eligibility, Coverage or Benefit Inquiry270/271 (bidirectional)3 | X12 | ||
99 | Tapestry Incoming Payment Order/Remittance Advice820 (batch)3 | X12 | ||
100 | Tapestry Incoming Health Care Claim Status Request276 (batch)3 | X12 | ||
101 | Tapestry Outgoing Health Care Claim Status Response277 (batch response to 276)3 | X12 | ||
102 | Tapestry Outgoing Health Care Claim Acknowledgement277CA (batch response to | X12 | ||
103 | Tapestry Outgoing Health Care Claim Pending Status Notification277P3 | X12 | ||
104 | Tapestry Incoming Benefit Enrollment and Maintenance834 (batch)3 | X12 | ||
105 | Tapestry Outgoing Benefit Enrollment and Maintenance834 (batch)3 | X12 | ||
106 | Tapestry Outgoing Health Care Claim Payment/Advice835 (batch)3 | X12 | ||
107 | Tapestry Incoming Health Care Claim: Institutional837 (batch)3 | X12 | ||
108 | Tapestry Outgoing Health Care Claim: Institutional837 (batch)3 | X12 | ||
109 | Tapestry Incoming Health Care Claim: Professional837 (batch)3 | X12 | ||
110 | Tapestry Outgoing Health Care Claim: Professional837 (batch)3 | X12 | ||
111 | Tapestry Incoming Health Care Claim: Professional with Dental Support837 (batch)3 | X12 | ||
112 | Tapestry Grouper/Pricer (OptumInsight) | Custom | ||
113 | Tapestry Grouper/Pricer (Generic) | Custom | ||
114 | Tapestry Code Editor | Custom |
Notes:
[***]
5 | Please discuss with Your Epic representative before implementing to ensure the interface is appropriate to meet the needs of Your intended workflow. |
[***]
Page 3 of 4
Notes Continued:
[***]
10. | Using HL7 version 2.4 Chapter 3 MPI Specifications |
11 | Interface to/from a supported encoding vendor product in Epic and encoding vendor supported configuration (front-end, back-end). Supports HIM coding in a supported third party encoder system. [***] |
[***]
# | Other Standard Interfaces Not Licensed as Interface Units | Available Formats | ||
1 | Incoming Infusion Documentation to [Vendor]1 | HL7 v2 | ||
2 | Outgoing Infusion Orders from [Vendor]1 | HL7 v2 | ||
(Including Incoming Infusion Verification from [Vendor]) | ||||
3 | ECG Integration Module (with MidMark)2 | Custom | ||
4 | Spirometry Integration Module (with MidMark)2 | Custom | ||
5 | Holter Integration Module (with MidMark)2 | Custom |
Notes:
1 | Please discuss with Your Epic representative before implementing to ensure this interface is available for Your particular [***] |
[***]
These interfaces and notes are subject to change.
The information in this document is proprietary and must be treated accordingly.
Page 4 of 4
Exhibit 1(c)
[***]
66
Exhibit 1(d)
[***]
Exhibit 1(e)
[***]
[***]
Exhibit 2(b)
Sample Implementation Schedule
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
EXHIBIT 3(a)
| Date Prepared: February 22, 2019 | |||||
BA#: | XWR #: | |||||
SLG#: | TLP #: | |||||
Budget Allocation |
Customer: |
| |
Project: |
|
Description: | Described Herein ☐ | Specs Attached ☐ | ||||||||
Schedule: | Standard ☐ | Rush ☐ | ||||||||
Release: | Next General ☐ | Special ☐ | ||||||||
When Release: | Business Hours (7:00 AM 8:00 PM) ☐ | After Hours ☐ | ||||||||
Retrofit: (only available if on the current version of Epic software) Yes ☐ | No ☐ |
[***]
Type of Quotation: | Estimate Only (actual cost may be higher or lower) | ☐ | ||||
Fixed Price (fixed cost for work - custom program includes 30-day warranty) | ☐ |
Approval of Enhancement During Implementation or Retrofit | N/A ☐ |
Epic Authorized Signature Date:
Enhancement requests made prior to 3 months after first live use of a product require the approval of Epics VP of R&D or President.
Retrofits require the approval of Epics VP of R&D or President (except those related to Electronic Claims and Interfaces may be signed by the Division Manager)
Quotation
Details | Time | |
Total Time and Cost: | $ (US$) |
Percentage of Total Cost for Monthly Maintenance (not applied to release time): | ||||||||
Custom Programming [***] | ☐ | Enhancement to the Application [***] | ☐ | |||||
Third party product (Please refer to the details above) | ☐ | Other [***] | ☐ |
Maintenance Charged: Upon Delivery ☐ Next Billing Period ☐ After 30 Day Warranty (Fixed Price Only) ☐ |
Performance (Advisory Only): Epic estimates that the requested change will affect system performance as follows: |
Minimal impact ☐ Small impact ☐ Moderate impact ☐ Significant impact ☐
Estimated Customer Testing Time: | Epic estimates that the requested change will require customer hours of testing. | |
This estimate is based on normal expectations of an acceptance tester. |
Epic Division Manager Signature: Date:
Acceptance
I authorize the work to begin as specified above. I understand that (a) if specifications change, prices may change, (b) if this Budget Allocation is over 60 days old, Epic may bill for the work at the then current rate or revise the quotation, (c) the actual hourly rate depends on the services performed and the person performing the services and (d) that the terms of the license agreement between Epic and Customer apply to this Budget Allocation. Except as otherwise provided in the license agreement, work associated with this Budget Allocation will be billed as incurred. I have authority on behalf of the Customer to authorize and sign this Budget Allocation.
I understand that the charges associated with this project will be charged against the existing budget.
Customer Signature: _________________________________________________________ Date: __________________________ |
Print Name: ________________________________________________________________ |
P.O. Number: _______________________________________________________________ (If applicable) |
EXHIBIT 3(b)
| Date Prepared:
Requestor: | |||||
CO#: | XWR #: | |||||
SLG#: | TLP #: | |||||
Change Order |
Customer: |
| |
Project: |
|
Description: | Described Herein ☐ | Specs Attached ☐ | ||||||||
Schedule: | Standard ☐ | Rush ☐ | ||||||||
Release: | Next General ☐ | Special ☐ | ||||||||
When Release: | Business Hours (7:00 AM 8:00 PM) ☐ | After Hours ☐ | ||||||||
Retrofit: (only available if on the current version of Epic software) Yes ☐ | No ☐ |
[***]
Type of Quotation: | Estimate Only (actual cost may be higher or lower) | ☐ | ||||
Fixed Price (fixed cost for work - custom program includes 30-day warranty) | ☐ |
Approval of Enhancement During Implementation or Retrofit | N/A ☐ |
Epic Authorized Signature: Date:
Any enhancement request made prior to or within 3 months after live, or Retrofits, requires the approval of the Clinical Products R&D Lead, the Billing/Access Products R&D Lead, or the Vice-President of Research & Development (except those related to Electronic Claims and Interfaces may be signed by the Division Manager).
Quotation
Details | Time | |
Total Time and Cost: | $ (US$) |
Percentage of Total Cost for Monthly Maintenance (not applied to release time): | ||||||||
Custom Programming [***] | ☐ | Enhancement to the Application [***] | ☐ | |||||
Third party product (Please refer to the details above) | ☐ | Other [***] | ☐ |
Maintenance Charged: Upon Delivery ☐ Next Billing Period ☐ After 30 Day Warranty (Fixed Price Only) ☐ |
Performance (Advisory Only): Epic estimates that the requested change will affect system performance as follows: |
Minimal impact ☐ Small impact ☐ Moderate impact ☐ Significant impact ☐
Estimated Customer Testing Time: | Epic estimates that the requested change will require customer hours of testing. | |
This estimate is based on normal expectations of an acceptance tester. |
Epic Division Manager Signature: Date:
Acceptance
I authorize the work to begin as specified above. I understand that (a) if specifications change, prices may change, (b) if this Change Order is over 60 days old, Epic may bill for the work at the then current rate or revise the quotation, (c) the actual hourly rate depends on the services performed and the person performing the services and (d) that the terms of the license agreement between Epic and Customer apply to this Change Order. Maintenance covers the system architecture the enhancement or other change was originally developed in. Converting the enhancement or change to other system architectures may require additional chargeable services. Except as otherwise provided in the license agreement, work associated with this Change Order will be billed as incurred. I have authority on behalf of the Customer to authorize and sign this Change Order.
I understand that the charges associated with this project are in addition to any previous budget.
Customer Signature: _________________________________________________________ Date: __________________________ |
Print Name: ________________________________________________________________ |
P.O. Number: _______________________________________________________________ (If applicable) |
Exhibit 3(c)
Date Prepared: | ||||
Order #: | ||||
Third-Party Tools Order
Customer: |
| |
Project: |
|
Description: | Described Herein ☐ | Specs Attached ☐ | ||||
Type of Quotation: | Estimate Only (actual cost may be higher or lower) | ☐ | ||||
Fixed Price | ☐ |
Quotation
Details | Costs | |||
|
| |||
Total Cost: | $ | (US$ | ) |
Maintenance Charged: Upon Delivery ☐ Next Billing Period ☐ After 30 Day Warranty (Fixed Price Only) ☐
Epic Signature: _______________________________________________________ Date: ____________________________
Acceptance
I authorize the work to begin as specified above. I understand that (a) if specifications change, prices may change, (b) if this Order is over 60 days old, Epic may bill for the work at the then current rate or revise the quotation, (c) the actual hourly rate depends on the services performed and the person performing the services and (d) that the terms of the license agreement between Epic and Customer apply to this Order. Except as otherwise provided in the license agreement, work associated with this Order will be billed as incurred. I have authority on behalf of the Customer to authorize and sign this Order.
I understand that the charges associated with this project are in addition to any previous budget.
Customer Signature: _____________________________________________________ Date: __________________________ |
Print Name: _____________________________________________________ |
P.O. Number: ______________________________________________________ (If applicable) |
EXHIBIT 4
[***]
[***]
[***]
[***]
1
[***]
[***]
[***]
2
Exhibit 5
BUSINESS ASSOCIATE EXHIBIT
Business Associate Addendum
This Business Associate Addendum (the Addendum) is incorporated into that certain License and Support Agreement (the Agreement) by and between AHS Management Company, Inc. (Covered Entity) and Epic Systems Corporation (Business Associate).
WHEREAS, Business Associate may maintain, transmit create or receive data for or from Covered Entity that constitutes Protected Health Information (as defined at 45 CFR §160.103) to perform tasks on behalf of Covered Entity;
WHEREAS, Covered Entity is or may be subject to the requirements of 42 U.S.C. 1320d et seq. enacted by the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Health Information Technology for Economic and Clinical Health Act (HITECH) and the implementing regulations set forth at 45 CFR Parts 160 and 164, Subparts A, C, D, and E as in effect on the effective date of the Agreement (HIPAA Regulations). As used herein, PHI refers to Protected Health Information maintained, transmitted, created or received by Business Associate for or from Covered Entity;
WHEREAS, to the extent required by the HIPAA Regulations and applicable state law, Business Associate is or may be directly subject to certain privacy and security obligations and penalty provisions of HIPAA, HITECH, the HIPAA Regulations and state law; and
WHEREAS, Business Associate owns and operates a web-based personal health records service, currently known as Lucy, (the PHR Service) that can be made available to patients of Covered Entity by way of a link provided on Covered Entitys patient portal website. The PHR Service allows patients to initiate transfers of data from Covered Entity to the PHR Service.
NOW, THEREFORE, the parties agree as follows:
1. Business Associate may use and disclose PHI only as expressly permitted by this Addendum or as required by law. Business Associate may use and disclose PHI as required to satisfy its obligations under the Agreement, provided that such use or disclosure of PHI would not violate the HIPAA Regulations if done by Covered Entity. Without limiting the generality of the foregoing, Business Associate shall not sell PHI or use or disclose PHI for purposes of marketing or fundraising in violation of 45 CFR §§ 164.502(a)(5)(ii) and 164.508(a)(3). Business Associate shall make reasonable efforts to limit its uses and disclosures of, and requests for, PHI (i) when practical, to the information making up a limited data set (as set forth at 45 CFR § 164.514(e)(2)); and (ii) in all other cases subject to the requirements of 45 CFR §164.502(b), to the minimum amount of PHI necessary to accomplish the intended purpose of the use, disclosure or request. To the extent Business Associate is to carry out an obligation of Covered Entity under Subpart E of 45 CFR § 164 of the HIPAA Regulations, Business Associate shall comply with the requirements of the Subpart E of 45 CFR § 164 of the HIPAA Regulations that apply to Covered Entity in the performance of such obligation.
2. Business Associate agrees to use and maintain reasonable and appropriate administrative, technical and physical safeguards to protect PHI from uses or disclosures not permitted by this Addendum. In addition, Business Associate agrees to comply with the applicable requirements of 45 CFR Part 164, subpart C of the HIPAA Regulations with respect to electronic PHI. Business Associate technical support representatives are currently trained to encrypt files that contain Protected Health
-1-
Information using [***] and to only share the passphrases or keys with those who need access to the information. [***]
3. To the extent Business Associate becomes aware of or discovers any use or disclosure of PHI in violation of this Addendum, any Security Incident (as defined at 45 CFR §164.304) , and any Breach of Unsecured Protected Health Information (both as defined at 45 CFR §164.402), Business Associate shall promptly report such use, disclosure, incident, or Breach to Covered Entity. All reports of Breaches of Unsecured Protected Health Information shall be made as soon as reasonaly practicable and without unreasonable delay, but in no event later than sixty (60) days after the date on which Business Associate discovers the Breach. A Breach shall be treated as discovered by Business Associate as of the first day on which such breach is known to Business Associate or, by exercising reasonable diligence, would have been known to Business Associate. A Breach is deemed known to Business Associate if the Breach is known, or by exercising reasonable diligence, would have been known to any person, other than the person committing the Breach, who is an employee, officer, or other agent of Business Associate. Business Associate shall, unless Business Associate and Covered Entity agree otherwise, train its employees regarding its policies and procedures pertaining to use and disclosure of Protected Health Information and to the detection and reporting of Breaches of Unsecured Protected Health Information, which policies direct Business Associates employees to report any Breaches of Unsecured Protected Health Information directly to Business Associates Security Officer or through internal reporting processes put in place and monitored by Business Associates Security Officer. Business Associates report to Covered Entity shall include the information specified at 45 CFR § 164.410 to the extent known by Business Associate. Business Associate shall mitigate, to the extent practicable, any harmful effect known to it of a use or disclosure of PHI by Business Associate not permitted by this Addendum.
With regard only to Breaches of Unsecured Protected Health Information that occur in connection with the PHR Service affecting individuals with whom Business Associate has a relationship by virtue of the PHR Service, [***]
4. In accordance with 45 CFR §§ 164.308(b)(2) and 164.502(e)(1)(i), Business Associate shall ensure that each subcontractor or agent that creates, receives, maintains, or transmits PHI on behalf of Business Associate agrees in writing to be bound by restrictions, terms and conditions that are at least as restrictive as those that apply to Business Associate pursuant to this Addendum.
5. In accordance with 45 CFR §164.524 and within fifteen (15) days of a request by Covered Entity for access to PHI about an individual contained in a Designated Record Set (as defined at 45 CFR §164.501), Business Associate shall make available to Covered Entity such PHI. In the event that any individual requests access to PHI directly from Business Associate, Business Associate shall within ten (10) days of receiving such request forward the request to Covered Entity. Any denials of access to the PHI requested shall be the responsibility of Covered Entity.
-2-
6. If Business Associate maintains PHI in a Designated Record Set for Covered Entity, in accordance with 45 CFR §164.526 and within fifteen (15) days of receipt of a request from Covered Entity for the amendment of an individuals PHI contained in a Designated Record Set (for so long as the PHI is maintained in the Designated Record Set), Business Associate shall provide such information to Covered Entity for amendment and incorporate any such amendments in the PHI. In the event a request for an amendment is delivered directly to Business Associate, Business Associate shall within ten (10) days of receiving such request forward the request to Covered Entity.
7. Except for disclosures of PHI by Business Associate that are excluded from the accounting obligation as set forth at 45 CFR §164.528 or regulations issued pursuant to HITECH, Business Associate shall record for each disclosure the information required to be recorded by covered entities pursuant to 45 CFR §164.528. In accordance with 45 CFR §164.528 and within twenty (20) days of notice by Covered Entity to Business Associate that it has received a request for an accounting of disclosures of PHI, Business Associate shall make available to Covered Entity the information required to be maintained pursuant to this Section 7. In the event a request for an accounting is delivered directly to Business Associate, Business Associate shall within ten (10) days of receiving such request forward the request to Covered Entity.
8. At Covered Entitys or HHS request, Business Associate shall make its internal practices, books and records relating to the use and disclosure of PHI available to HHS for purposes of determining Covered Entitys compliance with the HIPAA Regulations.
9. Business Associate is not authorized to use or disclose PHI in a manner that would violate the HIPAA Regulations if done by Covered Entity, provided that Business Associate may:
a. use the PHI for its proper management and administration and to carry out its legal responsibilities;
b. disclose PHI for its proper management and administration and to carry out its legal responsibilities, provided that disclosures are required by law, or Business Associate obtains reasonable assurances from the recipient that the PHI will remain confidential and used or further disclosed only as required by law or for the purpose for which it was disclosed to the recipient, and the recipient notifies Business Associate of any instances of which it is aware in which the confidentiality of the information has been breached;
c. use and disclose PHI to report violations of law to appropriate Federal and State authorities, consistent with 45 CFR § 164.502(j)(1);
d. aggregate the PHI in its possession with the PHI of other covered entities that Business Associate has in its possession through its capacity as a business associate to other covered entities, provided that the purpose of such aggregation is to provide Covered Entity with data analysis relating to the health care operations of Covered Entity; and
e. use PHI to create de-identified information, provided that the de-identification conforms to the requirements of 45 CFR § 164.514(b).
-3-
10. OMITTED.
11. This Addendum shall be effective as of the effective date of the Agreement and shall remain in effect until termination of the Agreement. Covered Entity may terminate this Addendum and the provisions of the Agreement that require or permit Business Associate to access Protected Health Information (or perform any other activity that would make Business Associate meet the definition of a Business Associate provided in 45 CFR § 160.103) effective immediately if it determines that Business Associate has materially breached this Addendum and failed to cure such breach within thirty (30) days of being notified by Covered Entity of the breach. If Covered Entity reasonably determines that cure of such breach is not possible, Covered Entity may terminate this Addendum and the provisions of the Agreement that require or permit Business Associate to access Protected Health Information effective immediately upon written notice to Business Associate. The parties understand and agree that termination of this Addendum by Covered Entity due to Business Associates uncured material breach shall constitute a material breach by Business Associate under the Agreement.
12. Upon termination of this Addendum, Business Associate shall either return or destroy all PHI that Business Associate still maintains in any form. Business Associate shall not retain any copies of such PHI. Notwithstanding the foregoing, to the extent that it is not feasible to return or destroy PHI, Business Associate may retain such PHI, provided that the terms and provisions of this Addendum shall survive termination of this Addendum and Business Associate shall only use or disclose such PHI solely for such purpose or purposes which prevented the return or destruction of such PHI. If the provisions of the Agreement that require or permit Business Associate to access Protected Health Information are terminated pursuant to any provision in Section 11 above, then the maintenance program under the Agreement will also terminate. Upon such termination, Business Associate will [***] Except as provided herein, any termination of the maintenance program or provisions of the Agreement that permit Business Associate to access Protected Health Information will not affect the parties other obligations or rights under the Agreement.
13. Nothing in this Addendum shall be construed to create any rights or remedies in any third parties or any agency relationship between the parties. The terms and conditions of this Addendum shall override and control any conflicting term or condition of the Agreement with regard to PHI. All non-conflicting terms and conditions of the Agreement (including without limitation Section 10) shall remain in full force and effect.
14. If the HIPAA Regulations are amended in a manner that would alter the parties rights or obligations as set forth in this Addendum, then the parties shall negotiate in good faith to amend the Addendum seeking to permit both parties to comply with the HIPAA Regulations.
15. Covered Entity does not intend to send unencrypted PHI to Business Associate in any form, including via email or on mobile devices such as USB drives. Should Covered Entity send any PHI that has not been encrypted, Covered Entity agrees that Business Associate is not responsible for any damages arising out of or relating to unencrypted PHI that Covered Entity sends to Business Associate in any form.
16. The respective rights and obligations of Business Associate under Section 12 of this Addendum survive the termination of this Addendum.
-4-
Exhibit 6
Enterprise Volume Definitions
[***]
Exhibit 7
Epic Support Policies
Support Available 24 x 7
Epic provides telephone consultation and assistance support to You through its technical services staff at any time, 24 hours per day and 7 days per week.
Where to Call
For all calls, whether during the Daytime Support Hours or the Nighttime Support Hours, call Epics general telephone number at ###-###-####. The Daytime Support Hours are 7 a.m. to 8:00 p.m., Monday through Friday, Central Time, excluding holidays (currently New Years Day, Good Friday, Memorial Day, July 4, Labor Day, Thanksgiving, Christmas Eve, Christmas, and New Years Eve). Nighttime Support Hours are all other times.
[***]
EXHIBIT 8
EPIC ERROR CORRECTION SERVICES
[***]
1
EXHIBIT 8
[***]
2
EXHIBIT 8
[***]
[***]
[***]
3
Attachment A to Exhibit 9
Epic
Instructions for Hardware Configuration Worksheet
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
Exhibit 9
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
Exhibit 10
Current Good Install Program
[***]
Exhibit 11
Sample Reports
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
Exhibit 12
2014 Certification Notification
Contents | ||||
[***] | 3 | |||
[***] | 5 | |||
[***] | 7 | |||
[***] | 9 | |||
[***] | 9 | |||
[***] | 10 | |||
[***] | 11 |
2
[***]
[***]
[***]
3
[***]
[***]
4
[***]
[***]
[***]
5
[***]
[***]
6
[***]
[***]
[***]
7
[***]
8
[***]
[***]
[***]
[***]
[***]
[***]
[***]
9
[***]
[***]
[***]
[***]
[***]
[***]
[***]
10
[***]
11
[***]
12
[***]
13
[***]
14
[***]
15
[***]
16
[***]
17
[***]
18
[***]
19
[***]
20
Exhibit 13
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
EXHIBIT 14
Epic Travel Policies
General
Before traveling to Your facilities, Epic must receive written authorization from You for the travel as provided in the Agreement. Epic will complete a travel authorization form which, unless agreed otherwise, will include the names of everyone who will be billing his or her travel expenses to You, the on-site dates for the personnel, and an estimate for all expenses. At Your option, You may approve a blanket travel authorization rather than an individual travel authorization for each trip. A blanket travel authorization includes a range of trips, reducing the number of travel authorizations submitted to You for approval. Epic will, where possible and in coordination with You, use reasonable efforts to plan its trips in sufficient enough time as available to pre-book fourteen days in advance to use economy flights. The following document outlines Epics current guidelines that it may revise from time to time.
Certain Reimbursable Expenses
Transportation:
Air: Coach-class seats generally are to be booked. Optional upgrades will not be reimbursed. Flights are chosen based on price and schedule. Epic will choose the most cost effective flight that otherwise satisfies its booking criteria (e.g. no double connections, fits any reasonable time constraints). If a charter would be of equal cost to or less expensive than commercial airfare due to the number of traveling staff, Epic may use a charter.
Ground: You will reimburse Epic for tolls, parking fees, a standard amount for mileage to and from the outbound airport, airport shuttle service, and taxi fares. Personal car mileage is based on the IRS set rate. Epic will normally rent cars from a national car rental chain to take advantage of its national discounted rates whenever feasible. Generally, Epic rents cars that will comfortably accommodate 3 or 4 employees with luggage and laptop computers rather than renting vehicles for each employee. Epic employees will make reasonable efforts to refuel rental cars prior to returning the cars.
Accommodations: You will reimburse Epic for the single occupancy cost of a standard room at an Epic standard hotel. If You have corporate discounts with preferred hotels that meet Epic standard hotel accommodations, Epics travel department will work with You to have Epic travelers stay at such hotels. In the event lodging at such a hotel or any other approved hotel is not available, travelers are expected to make reasonable efforts to utilize lodging with similar amenities and rates. Epic standard hotels are hotels that serve business travelers with suitable internet connections, business centers, safety (internally and in the surrounding locale), cleanliness, on-site or nearby food service, and on-site or nearby gathering areas to accommodate groups for work-related meetings, as well as short commuting distances and sufficient vacancies to accommodate the Epic staff on that trip.
Meals and Incidental Expenses. Epics current internal policies prohibit reimbursement for alcohol. Business-related expenses such as meals, cabs, tips, tolls, vending, phone, Internet, etc. will be reviewed by Epics accounting department for accuracy and be reimbursable. Employees are expected to exercise good judgment when leaving tips. Generally, a sensible tip of 15-20% is appropriate and will be reimbursable.
Non-Reimbursable Expenses
You will not reimburse Epic for the following expenses:
| Hotel movies |
| Entertainment |
| Sightseeing |
| Alcoholic beverages |
| Child or pet care |
| Damages to an employees personal vehicle |
| Lost or stolen funds or personal property |
| Parking tickets, speeding tickets, etc. |
| Travel insurance or rental car insurance offered by rental car companies |
| Insurance in connection with personal automobiles |
| Hotel health club memberships |
| Laundry service (unless Epic staff is on site for six consecutive days or more) |
| Personal services and personal supplies |
| Meals in Madison or the Madison area (other than at the Madison airport) |
| Any expense which is not bona fide for federal income tax purposes |
Documentation of Travel Expenses
Epic travelers generally are required to provide Epic with receipts for their travel expenses. Lodging receipts should include the name and location of the lodging, dates of stay and separate amounts for charges such as meals. Meal receipts should include the date, location, business purpose, and name of the person. On the occasion a receipt is lost or misplaced, Epics accounting department will obtain documentation from the traveler for the applicable expenses. Epics accounting department will monitor these instances to help keep them to a minimum.
Sharing Expenses with Other Organizations
Occasionally, it may be possible to combine travel to Your site with travel to or from another Epic customer site, and in such case, expenses can be shared with the other organizations. Epic employees are responsible for seeking reimbursement for expenses payable by others. If an Epic employee is taking a trip payable jointly by You and another entity, You will reimburse Your share of the actual expenses necessary for Your business. In no case may the reimbursement to the Epic employee from all sources exceed the total expenses incurred by the employee.
EXHIBIT 15
Litigation
1. | Uniloc USA, Inc. et al v. Epic Systems Corporation. Civil Action No. 6:2014-CV-00626 in the United States District Court for the Eastern District of Texas. |
2. | Preservation Wellness Technologies LLC v. Epic Systems Corporation. Civil Action No. 2:2015-cv-01561 in the United States District Court for the Eastern District of Texas. |
Care Everywhere Addendum
The following provisions apply to Your use of Care Everywhere to exchange patient information with Epic systems of other Care Everywhere Customers (as that term is defined in the Rules of the Road) and to exchange basic continuity of care information meeting the supported form with non-Epic systems, except as otherwise noted below. For the sake of clarity, the subset of Care Everywhere functionality supporting such exchanges between Epic systems was previously referred to as Care Epic and the subset of Care Everywhere functionality supporting such exchanges between Epic and non-Epic systems was previously referred to as Care Elsewhere. References to Care Epic or Care Elsewhere in the Rules of the Road and Governing Council Procedures will be read in that context.
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
ACC-NCDR® Registry Communication Module Addendum
The following provisions apply to Your use of the ACC-NCDR® Registry Communication Module.
I. | DEFINITIONS. |
All capitalized terms used in this Addendum and not defined herein but defined in the Agreement shall have the meanings assigned to such terms in the Agreement.
ACCF means the American College of Cardiology Foundation.
ACC-NCDR® Benchmarks means the aggregate information derived by an ACC-NCDR® Registry from data submitted to such ACC-NCDR® Registry.
ACC-NCDR® Registry means any one of the supported registries maintained by the ACCF to which You may submit pertinent data using the ACC-NCDR® Registry Communication Module.
Application Specifications means the requirements for the data submitted to an ACC-NCDR® Registry using the ACC-NCDR® Registry Communication Module.
Participant means an institution or practice (or a defined and consistent grouping within such an institution or practice) that is enrolled in one or more ACC-NCDR® Registries and eligible to submit pertinent data to such registry or registries.
II. | LICENSE. |
A. Participant Requirement. Each of Your or Your Affiliates institutions or practices (or a defined and consistent grouping within such institutions or practices) (each a Site) that accesses or uses the ACC-NCDR® Registry Communication Module must be a Participant in the ACC-NCDR® Registry or Registries to which such Site submits data, and You will limit access to the ACC-NCDR® Registry Communication Module only to such Sites. In addition, prior to Epic activating the license key for the ACC-NCDR® Registry Communication Module for use with the applicable ACC-NCDR® Registry, You will provide to Epic evidence satisfactory to Epic of such enrollment by those Sites in that ACC-NCDR® Registry to which such Sites will submit data using the ACC-NCDR® Registry Communication Module. If at any time during a Subscription Year (as defined below), any Site that accesses or uses the ACC-NCDR® Registry Communication Module is no longer a Participant or stops participating in an ACC-NCDR® Registry, You shall immediately provide Epic with written notice, and You shall, or shall permit Epic to, deactivate such Sites access to such ACC-NCDR® Registry.
B. Benchmark Data. You will not enter the ACC-NCDR® Benchmarks into the Program Property (including without limitation the ACC-NCDR® Registry Communication Module) for reporting purposes.
C. Updates. You understand that the ACCF specifies the Application Specifications. If the ACCF modifies the Application Specifications You will install any upgrades to the ACC-NCDR® Registry Communication Module Epic provides to You to address the changes to the Application Specifications prior to the time the ACCF requires Participants to utilize such updated specifications to submit data. You acknowledge that if You do not upgrade to an updated ACC-NCDR® Registry Communication Module You may not be able to submit data to ACC-NCDR® Registries.
D. Ownership. Epic does not own any right, title, or interest in the any data stored by or entered into the ACC-NCDR® Registry Communication Module.
1
III. | TERM. |
A. Term and Subscription Fees. The subscription year for the ACC-NCDR® Registry Communication Module is from January 1 to December 31 (a Subscription Year). For each Subscription Year, You will pay Epic the then-current annual subscription fee with respect to Your use of the ACC-NCDR® Registry Communication Module with the applicable ACC-NCDR® Registry. The initial annual subscription fee for use of the ACC-NCDR® Registry Communication Module with the applicable ACC-NCDR® Registry shall be prorated from the date Epic first activates the license key for the ACC-NCDR® Registry Communication Module for use with that ACC-NCDR® Registry to December 31 of that Subscription Year. In subsequent Subscription Years, the full annual subscription fee for such use will be due each January 31. Notwithstanding anything in the Agreement, subscription fees are subject to annual increases and increases due to increases in Your Licensed Volume. If Your Licensed Volume increases, any incremental annual subscription fees for the ACC-NCDR® Registry Communication Module will be due beginning as of the date the previous Licensed Volume was exceeded. If there is any change in the then-current annual subscription fee (other than for increases in Your Licensed Volume), Epic will provide You with written notice of such new fee on or before December 15 of the then current Subscription Year. Notwithstanding anything contained herein to the contrary, if at any time none of the Sites is a Participant or is participating in any ACC-NCDR® Registries, then You shall immediately provide Epic with written notice, Your license to the ACC-NCDR® Registry Communication Module shall immediately terminate, and You shall permit Epic to deactivate the ACC-NCDR® Registry Communication Module.
B. Amendment to Addendum. Epic reserves the right to amend this Addendum in order to comply with the contractual requirements of the ACCF related to Epics licensing of the ACC-NCDR® Registry Communication Module. Epic will provide You with written notice of its intent to amend this Addendum and shall provide You with the proposed amendment by December 15 of the current Subscription Year.
C. Right to Terminate. Upon receipt of a notice under Section III.A. (regarding a change in the annual subscription fee) or under Section III.B. (regarding an amendment of this Addendum), You will have fifteen (15) days to provide Epic with written notice terminating Your use of the ACC-NCDR® Registry Communication Module if You are not willing to accept the change in the annual subscription fee or amendment(s) to the Addendum.
IV. | NOTICE. |
The ACC-NCDR® Registry Communication Module incorporates aspects of the ACCF Specifications, including data forms, formats, definitions, codes, and codebooks, file specifications, file transfer protocols, procedural guides, application specifications, and publications and reports developed by the ACCF in support of the operation of the ACC-NCDR® Registries which are the sole and exclusive property of the ACCF.
2
INTERSYSTEMS CACHÉ SOFTWARE ADDENDUM
STANDARD ADDENDUMINTERSYSTEMS
A part of the software supplied to You by Epic consists of the software (either M or Caché, as applicable) from InterSystems Corporation of Cambridge, Massachusetts. The following terms and conditions apply to the sublicense of the Sublicensed Software from Epic to You, the User, as required and authorized by InterSystems.
1. | REPRESENTATION OR WARRANTIES OF INTERSYSTEMS |
EXCEPT AS EXPRESSLY PROVIDED HEREIN, INTERSYSTEMS DOES NOT MAKE AND SHALL NOT BE DEEMED TO HAVE MADE ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, AS TO THE CONDITION, MERCHANTABILITY, TITLE, DESIGN, OPERATION OR FITNESS FOR A PARTICULAR PURPOSE OF THE SUBLICENSED SOFTWARE OR ANY OTHER REPRESENTATION OR WARRANTY WHATSOEVER, EXPRESSED OR IMPLIED, WITH RESPECT TO THE SUBLICENSED SOFTWARE.
a. | InterSystems hereby represents and warrants as follows: |
(i) | InterSystems has (a) valid title to the Sublicensed Software, free of all liens, encumbrances, restrictions and claims of others, (b) the right to license the same to Epic, and (c) the right to license Epic to grant sublicenses of the type granted to User by Epic. |
(ii) | Any Sublicensed Software services performed hereunder or under any Sublicensed Software maintenance agreement between InterSystems and Epic shall be performed by highly skilled personnel qualified to perform such services and such services shall be performed in a professional and workmanlike manner in accordance with the then prevailing standards of the computer services industry. |
(iii) | The Sublicensed Software and its use do not and will not violate or infringe upon any currently issued United States patent or any copyright, trade secret or other property right (whether conferred by statute, code, common law, or otherwise) of any other person or entity that is valid or enforceable in the United States or in any country in which Epic now maintains or hereafter maintains any office, property or data processing services. |
(iv) | The Sublicensed Software, as delivered by InterSystems, is free from material defects in manufacturing and materials and shall operate substantially in conformance with the Applicable Specifications relating to such Sublicensed Software until thirty (30) days after the later of (a) initial delivery of the Sublicensed Software to User, and (b) the date when User first uses the Epic Program Property, whether for testing, training, processing of patient data or other purpose (the Software Warranty Period). |
b. | During the Software Warranty Period, InterSystems shall promptly provide, through Epic and at no charge to User, corrections, modifications or additions to the Sublicensed Software in the event that Epic notifies InterSystems in writing of any substantive errors in the Sublicensed Software. User shall assist Epic and, upon request, InterSystems, in identifying the circumstances in which any such substantive errors are discovered and, if requested by Epic or InterSystems, shall document the existence of the same. In no event shall InterSystems have any responsibility to correct any data base errors or errors or damages caused by or arising out of hardware defects or input errors or resulting from changes to or modifications of the Sublicensed Software made by Epic or User without the express written approval of InterSystems. |
1
c. | All warranty claims or other claims pursuant to this section shall be made to InterSystems through Epic. |
d. | The foregoing representations and warranties are by InterSystems only. Epic makes no representations or warranties pursuant to, and Epic shall have no liability arising out of, this section. |
2. | INDEMNIFICATION OF INTERSYSTEMS |
a. | InterSystems shall, and hereby agrees to, indemnify, defend, and hold harmless User and its officers, employees, agents, and representatives, from and against any and all third-party claims, actions damages, liabilities, costs, and expenses (including, without limitation, reasonable attorneys fees and expenses arising out of the defense of any claim, whether proven or not) arising from or based upon a breach by InterSystems of any of its representations or warranties in Section 1(a)(i) or 1(a)(iii) above. |
b. | (i) | The indemnities specified in Section 2(a) above shall not apply to a specific claim, action, or allegation unless User shall have provided written notice of such claim, action, or allegation to InterSystems as soon as practicable, and shall have granted InterSystems full opportunity to control the response thereto and the defense thereof, including without limitation any agreement relating to the settlement thereof; provided, however, that User shall have the right to monitor, at its own expense, InterSystems defense of any such claim, action, or allegation and, if necessary, to preclude a default judgment or other loss of rights, to file pleadings on its behalf in the event InterSystems fails to fulfill its obligation to defend User pursuant to this Section 2. |
(ii) | In the case of a claim based on a breach of the representation and warranty contained in Section 1(a)(iii) above, the indemnity specified in Section 2(a) shall not apply to any claim, action, or allegation (or any judgment or order related thereto) based upon: (a) the use by User of the Sublicensed Software in combination with other hardware or software not supplied by InterSystems, where the use of the Sublicensed Software alone is not claimed or alleged to be an infringement; (b) the modification or alteration of the Sublicensed Software in a manner that is not approved by InterSystems; or (c) the failure by User to implement a release or engineer change order for the Sublicensed Software issued by InterSystems and supplied to User by Epic (which release or change order does not preclude the Sublicensed Software from meeting the standards specified in Section 1(b)). |
c. | In the event that the Sublicensed Software (or any component or part thereof) becomes the subject of any claim, action, or allegation of the type specified in Section 1(a)(iii), InterSystems shall promptly use all reasonable efforts at its expense: (a) to procure for User the right to continue using the Sublicensed Software (or applicable component or part thereof); or (b) if such continued use cannot be so procured, to modify it to become non-infringing; or (c) if such modification cannot be so implemented, to provide substitute hardware, software, or other products, components or parts of similar capability acceptable to and approved by User, which approval shall not be unreasonably withheld or delayed. |
2
d. | THE FOREGOING STATES THE ENTIRE OBLIGATION OF INTERSYSTEMS WITH RESPECT TO THE INFRINGEMENT OF PATENTS, COPYRIGHTS, AND OTHER PROPRIETARY RIGHTS. |
e. | The foregoing indemnification is by InterSystems only. Epic makes no indemnification pursuant to, and Epic shall have no liability arising out of, this section. |
3. | LIMITATION OF LIABILITY |
Except as specifically set forth in Sections 1 and 2 above, InterSystems shall have no liability of any kind to the User, whether direct or indirect, for any loss or damage suffered by the User or its employees, agents or representatives, or customers or patients using the facilities or retaining the services of the User, as a result of or arising out of the Sublicensed Software.
The liability of InterSystems for any loss or damage directly or indirectly suffered by User as a result of any defects in the Sublicensed Software or any acts of omission of InterSystems or its officers, employees, agents, or representatives hereunder shall in no event exceed any amount equal to the license fees paid or owed to InterSystems by Epic in respect of the specific Sublicensed Software or services on account of which User has suffered loss or damage. The foregoing shall not apply to claims of property damage or bodily injury or those claims based on the willful misconduct of InterSystems.
WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, IN NO EVENT SHALL INTERSYSTEMS BE LIABLE FOR SPECIAL, INCIDENTAL, EXEMPLARY, INDIRECT OR CONSEQUENTIAL DAMAGES BASED UPON BREACH OF WARRANTY, BREACH OF CONTRACT, NEGLIGENCE, STRICT TORT, OR ANY OTHER LEGAL THEORY EVEN IF INTERSYSTEMS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. SUCH DAMAGES SHALL INCLUDE, WITHOUT LIMITATION, LOSS OF PROFITS, LOSS OF SAVINGS OR REVENUE, LOSS OF USE OF THE LICENSED SOFTWARE OR ANY ASSOCIATED EQUIPMENT OR SOFTWARE, COST OF CAPITAL, COST OF ANY SUBSTITUTE EQUIPMENT, FACILITIES OR SERVICES, DOWNTIME, THE CLAIMS OF THIRD PARTIES (INCLUDING, WITHOUT LIMITATION, CUSTOMERS OR OTHER PERSONS USING THE FACILITIES OF THE USER), AND PROPERTY DAMAGE.
4. | PROPRIETARY RIGHTS AND CONFIDENTIALITY |
a. | The Sublicensed Software and related materials (including, without limitation, the System Documentation) are and shall remain, the sole property of InterSystems or one or more of its affiliates. No right to print or copy, in whole or in part, any such Sublicensed Software, System Documentation or related materials is granted hereunder except as herein expressly provided. The Sublicensed Software is licensed for a specific Platform (a Platform is a family of computers that use the same operating system and have a software compatible CPU instruction set and architecture; Platform information is available on the InterSystems website). Except in the case of Platform Independent Licenses, a transfer fee is charged by InterSystems if the license is transferred from one Platform to another. |
b. | EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT, THE USER AGREES NOT TO (i) DECOMPILE, DISASSEMBLE OR REVERSE ENGINEER THE LICENSED SOFTWARE OR (ii) USE OR DISCLOSE OR DIVULGE TO OTHERS ANY DATA OR INFORMATION RELATING TO THE LICENSED SOFTWARE AND/OR THE TECHNOLOGY, IDEAS, CONCEPTS, KNOW-HOW AND TECHNIQUES EMBODIED THEREIN. |
3
c. | The obligations of confidentiality and non-use described in Section 4(b) above shall not be deemed to include disclosure or other use of such data or information to the extent that the User can prove the same is or becomes publicly known within the public domain (other than by acts attributable to the User or any of its officers, agents, shareholders of privately-held companies, employees or representatives). Information shall not be deemed to be in the public domain by reason of the general licensing and other commercial disposition of the Sublicensed Software by InterSystems in the ordinary course of its business. The existence of a copyright notice shall not cause, or be deemed or construed as causing, the Sublicensed Software or System Documentation to be published copyright work or to be in the public domain. |
d. | Nothing contained in this Section shall prohibit the User or any of its officers, agents, shareholders, employees or representatives from: |
(i) | using his or its general technical skills when not otherwise inconsistent with the terms hereof; or |
(ii) | disclosing data or information pursuant to any enforceable administrative or judicial order, provided, however, that the User first notifies InterSystems of the entry or existence of such order and of the Users intention to comply with its terms. Data or information shall not be deemed to be in the public domain solely by reason of any such order. |
e. | The User further agrees: |
(i) | except for back-up security purposes, not to copy, reproduce or duplicate, or allow to be copied, reproduced or duplicated, in whole or in part, the Sublicensed Software, System Documentation or any related materials without the prior written consent of InterSystems; |
(ii) | not to provide or otherwise make available any Sublicensed Software, System Documentation or related materials in any form to any other person or organization, without the prior written consent of InterSystems; and |
(iii) | that it will take appropriate action with its officers, agents, shareholders, employees or representatives, by instruction, agreement or otherwise, to satisfy its obligations under this Agreement with respect to use, copying, modification, and protection and security of the Sublicensed Software, System Documentation and related materials. Without limiting the generality of the foregoing, the User shall in any event devote the same degree of care to protecting the Sublicensed Software and System Documentation as it devotes to the protection of its own confidential and proprietary information. |
f. | In the event of any breach or threatened breach of the provisions of this Section, InterSystems shall, in addition to all other rights and remedies available to it at law or in equity, be entitled to a temporary or permanent decree or order restraining and enjoining such breach and the User shall not plead in defense thereto that there would be an adequate remedy at law, it being hereby expressly acknowledged and understood that damages at law will be an inadequate remedy in the event of such a breach or threatened breach. |
4
g. | If, having complied with the foregoing provisions of this Section, the User has actual notice of any unauthorized possession, use or knowledge of any part of the Sublicensed Software or physical embodiment thereof, or of the System Documentation or any other information made available pursuant to this Agreement by anyone else other than persons authorized by this Agreement to have such possession, use or knowledge, the User agrees to notify InterSystems promptly of the circumstances surrounding such unauthorized possession, use or knowledge. |
h. | The User shall not remove or destroy any proprietary markings or proprietary legends placed upon or contained within the Sublicensed Software or any related materials or System Documentation in the Users possession. |
i. | Subject to other restrictions contained herein, User shall have the right to grant access to the Sublicensed Software to its employees. In addition, the Sublicensed Software may also be used, solely to run Epics Program Property (and not to develop or run other applications), by other organizations to whom the User provides access to Epics Program Property, unless the providing of such access is the primary relationship between the User and other said organizations. |
j. | User shall use the Sublicensed Software only to run the Epic Program Property or applications developed by the User to be run in conjunction with the Epic Program Property, but the primary use must be to run the Epic Program Property. |
5. | DEFINITIONS |
For the purposes of this Addendum only, the following definitions apply to the capitalized terms as follows.
Applicable Specifications means, in the case of any Sublicensed Software, the functional, performance and operational characteristics of such Sublicensed Software as set forth in the System Documentation.
Sublicensed Software means the computer programs (which, unless otherwise determined by InterSystems in its sole discretion, shall be in Object Code version only) licensed by InterSystems through Epic to You hereunder, which are more fully identified as InterSystems software in Exhibit 1(a) to the Epic Standard License Agreement of which this is a part, together with any enhancements and related items which InterSystems may announce while the Agreement is in effect.
System Documentation means the documentation, reference manuals, user guides and other standard visually readable materials relating to the Sublicensed Software furnished by InterSystems to Epic and licensed by Epic to You hereunder.
User and You mean the licensee in the Epic License and Support Agreement to which this Intersystems Software Addendum is a part.
5
SQL ADDENDUM
This is a software license (the Sublicense and Limited Warranty) authorized by Knowledge Based Systems, Inc. (KBS), a Virginia corporation, with its mailing address at 43053 Midvale Court., Ashburn, VA 20147. The KB_SQL Software (SOFTWARE) is sublicensed by Epic to You as the end user; it is not sold. The SOFTWARE is subject to the following license terms and conditions.
1. LICENSE
1.1 | Copyright |
The SOFTWARE is copyrighted material. Once You have paid the required license fee, You may use the SOFTWARE for as long as You do not violate the copyright and if You follow these simple rules.
1.2 | Maximum Number of Users |
You may use the SOFTWARE on any computer or computer network for which it is designed so long as no more than the specified number of concurrent user(s) (see comments in Exhibit 1(a) to the main license agreement with Epic) use it at any one time. Your license to use the SOFTWARE allows use of the SOFTWARE both (a) by the specified number of concurrent users in a single production environment, AND, simultaneously, (b) by the specified number of concurrent users in a single shadow environment for real-time or near-real time data access and reporting. Alternatively, you may use the SOFTWARE in two shadow environments for real-time or near-real time data access and reporting, so long as You make no use of the SOFTWARE in any production environment. If Your number of concurrent users in any environment exceeds your licensed level of concurrent users, You must upgrade Your license to an appropriate number of users or pay for additional copies of the SOFTWARE. Additionally, use of the SOFTWARE for real-time or near-real time data access and reporting in more than two environments as described in this paragraph (either production and one shadow or two shadows), requires the purchase of additional copies of the SOFTWARE for each such additional environment.
1.3 | Copies |
You may make copies of the SOFTWARE for backup purposes and for use in non-production environments in conjunction with Epic Software. All such copies, together with the original, must be kept in Your possession or control.
For purposes of this paragraph:
1.3.1 | a shadow environment is for backup purposes if the SOFTWARE gets copied to the environment only due to replication, or if the SOFTWARE is installed on the environment for disaster recovery, as long as (in either case) the SOFTWARE is not used in the shadow environment; |
1.3.2 | environments such as Test, Release, and Train (whether created as shadows or otherwise), in which no useful, production use of the SOFTWARE occurs, are non-production environments; |
1.3.3 | a shadow environment in which the SOFTWARE is used for real-time (or near real time) data access and reporting purposes (i.e., one which has the purpose or effect of load-balanced reporting) requires appropriate licensing as provided in paragraph 1.2. |
1.4 | Modifications |
You may not make any changes or modifications to the licensed SOFTWARE, and You may not decompose, disassemble, or otherwise reverse engineer the SOFTWARE. You may not rent or lease it to others.
1.5 | Breach of this Agreement |
In the event You breach this Sublicense and Limited Warranty, Epic or KBS may, at their sole option in addition to other remedies, terminate Your right to use the SOFTWARE.
1.6 You acknowledge that you do not have the right to resell or sublicense SOFTWARE under any circumstances.
2. USING COMPILED QUERY ROUTINES
2.1 | Query Routines |
Compiled Query Routines that are generated by the KB_SQL compiler may be used, given away or sold without additional license or fees.
1
3. LIMITED WARRANTY
3.1 | Distribution Media and Documentation |
KBS warrants the physical distribution media (diskettes, tape, etc.) and physical documentation shipped with the SOFTWARE to be free of defects in materials and workmanship for a period of 60 days from the purchase date. If KBS receives notification within the warranty period of defects in materials or workmanship, and such notification is determined to be correct, KBS will replace the defective distribution media or documentation.
3.2 | Product Returns |
DO NOT RETURN ANY PRODUCT UNTIL YOU HAVE CALLED THE KBS CUSTOMER SERVICE DEPARTMENT AND OBTAINED AUTHORIZATION FOR SUCH RETURN.
3.3 | No Other Warranties |
KBS SPECIFICALLY DISCLAIMS ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. UNDER NO CIRCUMSTANCES SHALL EPIC HAVE ANY LIABILITY WHATSOEVER WITH RESPECT TO THE SOFTWARE OR ANY WARRANTY HEREUNDER.
3.4 | Breach of this Limited Warranty |
THE ENTIRE AND EXCLUSIVE LIABILITY AND REMEDY FOR BREACH OF THIS LIMITED WARRANTY SHALL BE LIMITED TO REPLACEMENT OF DEFECTIVE DISTRIBUTION MEDIA OR DOCUMENTATION AND SHALL NOT INCLUDE OR EXTEND ANY CLAIM FOR OR RIGHT TO RECOVER ANY DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF GOODWILL, PROFIT, USE OF MONEY, DATA OR USE OF THE SOFTWARE, OR SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES OR OTHER SIMILAR DAMAGE CLAIMS, EVEN IF KBS HAS BEEN SPECIFICALLY ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IN NO EVENT WILL KBSS LIABILITY FOR ANY DAMAGES TO YOU OR ANY OTHER PERSON EVER EXCEED THE LOWER OF SUGGESTED LIST PRICE OR ACTUAL PRICE PAID FOR THE LICENSE TO USE THE SOFTWARE, REGARDLESS OF THE FORM AND LEGAL THEORY OF THE CLAIM INCLUDING BREACH OF EXPRESS OR IMPLIED WARRANTIES, BREACH OF CONTRACT, MISREPRESENTATIONS, NEGLIGENCE, STRICT LIABILITY IN TORT, OR OTHERWISE ARISING OUT OF THIS SUBLICENSE AND LIMITED WARRANTY.
4. GOVERNING LAW AND GENERAL PROVISIONS
4.1 | Commonwealth of Virginia |
This Sublicense and Limited Warranty shall be construed, interpreted and governed by the laws of the Commonwealth of Virginia notwithstanding Virginias conflict of law doctrine and any action hereunder shall be brought only in Virginia.
4.2 | Choice of Forum |
The parties agree that all litigation to continue or enforce this Agreement shall be brought in the United States District Court for the Eastern District of Virginia (Alexandria Division). The parties hereby consent to the exclusive jurisdiction of that court, and universally waive objection based on venue or inconvenient forum to litigation in that court.
4.3 | Severability, Contribution, and Modification |
If any provision is found void, invalid or unenforceable it will not affect the validity of the balance of this Sublicense and Limited Warranty which shall remain valid and enforceable according to its terms. If any remedy hereunder is determined to have failed of its essential purpose, all limitations of liability and exclusion of damages set forth herein shall remain in full force and effect. This Sublicense and Limited Warranty may only be modified in writing signed by You and a specifically authorized representative of KBS.
4.4 | Restricted Rights Legend |
Use, duplication or disclosure by the U.S. Government of the computer software and documentation in this package shall be subject to the restricted rights under DFARS ###-###-#### applicable to commercial computer software. All rights not specifically granted in this statement are reserved by KBS.
2
BUSINESS OBJECTS ADDENDUM
This is a product license granted by Business Objects Software Limited, an Irish corporation (Business Objects). The Business Objects software and documentation (Software) is licensed to You, the end user; it is not sold. The product is subject to the following license terms and conditions:
1. | Definitions. For purposes of this Addendum: |
OEM shall mean Epic Systems Corporation.
Product or Products shall mean the machine readable object code of the Business Objects Software Limited software sublicensed by OEM to You for use as provided herein, together with the Business Objects user documentation for such software and any updates to such software and user documentation.
Licensee shall mean You.
2. | License Grant. Subject to Licensees compliance with this Addendum, Licensee is granted a non-exclusive and non-transferable license to use the Products for Licensees internal business purposes in accordance with the product use rights set forth below. |
3. | Restricted License. The licenses granted to Licensee for use of the Products are NOT general purpose licenses for use of the Products throughout Licensees enterprise. Instead, the licenses are restricted to use only in conjunction with Licensees use of OEM Products (including OEMs data warehouse), which may include data from other sources besides the OEM Products, including third party data used by the OEM Products and data interfaced into OEM Products from other systems as long as the data is used to support reporting from the OEM Products. However, the Business Objects Products can not be used to report directly against non-OEM Products. |
4. | Report Distribution. There are no restrictions limiting Licensees ability to automatically and/or regularly deliver, share or distribute reports created using the Products in any file format. |
5. | Other Restrictions. Except as expressly permitted by this Addendum, Licensee may not: (i) lease, loan, resell, sublicense, or otherwise distribute a Business Objects Product; (ii) use a Business Objects Product to provide or operate Application Service Provider (ASP), service bureau, marketing, training, outsourcing services, or consulting services, or any other commercial service related to the Business Objects Products; (iii) use a Business Objects Product to develop a Business Objects Product which is competitive with any of the Business Objects Products; (iv) permit third-party access to, or use of, the Business Objects Products, except as expressly permitted herein; (v) distribute or publish keycode(s) to the Business Objects Products; or (vi) use unauthorized keycode(s). Licensee shall notify Business Objects if Licensee becomes aware of any unauthorized third party access to, or use of, a Business Objects Product. Notwithstanding item (ii), Licensee may provide access to and use of the Products to the same extent Licensee may provide access to and use of the OEM Products under Licensees license agreement with OEM, including access to and use of the Products by any of your Affiliates provided that your business relationship with such Affiliate does not exist primarily for the purpose of providing such person or entity with access to the Products, and that such access is only a nominal part of the solution or service that Licensee provides to its Affiliates. |
6. | Outsourcers. Outsourcer means a third party other than OEM engaged by Licensee for data processing, consulting, product customization, or internal information management at a designated Licensee or Outsourcer site. If Licensee contracts with an Outsourcer, Licensee may permit access to, and use of, the Products by the Outsourcer, provided that: (i) the Outsourcer complies with the terms of this Addendum and accesses and uses the Products solely for purposes of rendering services to Licensee; and (ii) the total number of licenses used by Licensee and Outsourcer must not exceed the number of licenses ordered. Licensee shall be responsible for Outsourcers compliance with the terms of this Addendum. |
7. | Duplication of Product. Licensee may make a reasonable number of archival copies of the Products for inactive backup purposes. All Product copyright, trademark, patent, and related proprietary notices incorporated in or fixed to the Product shall be duplicated by Licensee on all copies or extracts thereof and shall not be altered, removed, or obliterated. |
8. | Third Party Beneficiary. Licensee is notified that Business Objects Software Limited (Business Objects) is a third party beneficiary to this Addendum to the extent it relates to use of the Products. Such provisions are made expressly for the benefit of Business Objects and are enforceable by both OEM and Business Objects. |
9. | Product Ownership and Restrictions. All intellectual property rights and title to the Business Objects Product shall remain with Business Objects and/or its suppliers and no interest or ownership therein is conveyed to Licensee. No right to modify (even for purposes of error correction), adapt, or translate the Business Objects Product or create derivative works therefrom is granted to Licensee, except as necessary to configure the Business Objects Product using the menus, options and tools provided for such purposes and contained in the Business Objects Product. Licensee shall not use the Business Objects Product to develop a Business Objects Product that converts the report file |
1
(.RPT) format to an alternative report file format used by any general-purpose report writing, data analysis, or report delivery Business Objects Product that is not the property of Business Objects or alter, disassemble, decompile, translate, adapt, or reverse-engineer the report file (.RPT) format. Nothing in this Addendum shall be construed to mean, by inference or otherwise, that Licensee has any right to obtain Business Objects Product source code. Except as required to be permitted by applicable law, reverse compiling (including reverse compiling to ensure interoperability), reverse engineering and other source code derivation of the Business Objects Product is prohibited. If Licensee wishes to exercise any right to reverse engineer to ensure interoperability in accordance with applicable law, YOU shall first provide written notice to Business Objects and permit Business Objects, at its discretion, to make an offer to provide information and assistance reasonably required to ensure Business Objects Product interoperability with other Licensee products for a fee to be mutually agreed upon (if any). |
10. | Limited Warranties. Business Objects warrants that, during the ninety (90) days following your receipt of the Business Objects Products (the Warranty Period), the Business Objects Products will operate substantially in conformity with the applicable Documentation. Within the Warranty Period, if Licensee detects a defect in a Business Objects Products physical media, Licensee may return the defective media to Business Objects and Business Objects will replace it free of charge. Provided that Business Objects is notified in writing of a Business Objects Products nonconformance with the warranty set forth in this Section 10 within the applicable Warranty Period, Business Objects shall, at its option: a) repair or replace the defective Business Objects Product, or b) refund the license fees paid for the Business Objects Product in exchange for a return of the defective Business Objects Product. This Section 10 is Licensees exclusive remedy for breach of the limited warranties in this Section 10. The above warranties specifically exclude defects resulting from accident, abuse, misapplication or unauthorized repair, modifications, or enhancements. Business Objects does not warrant that use of the Business Objects Products will be uninterrupted or error free. EXCEPT FOR EXPRESS WARRANTIES STATED IN THIS SECTION 10 AND TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE BUSINESS OBJECTS PRODUCTS AND SERVICES ARE PROVIDED AS IS, AND BUSINESS OBJECTS AND ITS SUPPLIERS DISCLAIM ALL OTHER WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY IMPLIED WARRANTY (I) OF MERCHANTABILITY, (II) OF FITNESS FOR A PARTICULAR PURPOSE, OR (III) OF NON-INFRINGEMENT OF THIRD PARTY RIGHTS. |
11. | Third Party Claims. Business Objects shall: (i) defend, or at its option settle, any claim by a third party against Licensee on the basis of a Business Objects Products infringement of any United States or Canada patent, trademark, copyright or trade secret; and (ii) pay any final judgment entered against Licensee on such claim or any settlement entered into by Business Objects on Licensees behalf, provided that: Licensee (1) notifies Business Objects promptly of each such claim; (2) gives Business Objects sole control of the defense and/or settlement of the claim; (3) fully cooperates with Business Objects in the defense or settlement of the claim; and (4) takes no action that may prejudice Business Objects ability to defend the claim. If all or any part of the Business Objects Product is, or in the opinion of Business Objects is likely to become, the subject of a claim of infringement, Business Objects may at its sole discretion: (w) procure for Licensee the right to use the Business Objects Product or the affected part thereof; (x) replace the Business Objects Product or affected part with other suitable software; (y) modify the Business Objects Product or affected part to make it non-infringing; or (z) if none of the foregoing remedies is commercially feasible as determined by Business Objects in its sole discretion, Business Objects shall refund, upon return of the infringing Business Objects Product, a pro-rated (over a 36 month period on a straight-line basis) portion of the payments paid by LICENSEE to Business Objects for the Business Objects Product or the affected part. Business Objects shall have no indemnity or other obligations to the extent a claim is based on: (a) failure to use an update provided by Business Objects, if infringement could have been avoided by use of the updated version; (b) combination, operation, or use of Business Objects Products with other Business Objects Products not provided by Business Objects, if such infringement would have been avoided in the absence of such combination, operation, or use; (c) Licensees use of Business Objects Product in any manner inconsistent with the applicable license terms and conditions; or (d) modification, alteration, or enhancement to the Business Objects Product not performed or expressly authorized by Business Objects. THE FOREGOING PROVISIONS OF THIS SECTION STATES THE ENTIRE LIABILITY AND OBLIGATION OF BUSINESS OBJECTS AND THE EXCLUSIVE REMEDY OF LICENSEE FOR CLAIMS OF INFRINGEMENT OF THIRD PARTY RIGHTS. |
12. | LIMITATION OF LIABILITY. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT WILL BUSINESS OBJECTS OR ITS SUPPLIERS BE LIABLE TO LICENSEE OR ANY THIRD PARTY FOR ANY INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION, ANY LOST PROFITS OR REVENUES, LOSS OR INACCURACY OF ANY DATA, OR COST OF SUBSTITUTE GOODS, REGARDLESS OF THE THEORY OF LIABILITY (INCLUDING NEGLIGENCE) AND EVEN IF BUSINESS OBJECTS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. BUSINESS OBJECTS AND ITS SUPPLIERS AGGREGATE LIABILITY TO LICENSEE FOR ACTUAL DIRECT DAMAGES FOR ANY CAUSE WHATSOEVER SHALL BE LIMITED TO THE CUMULATIVE BUSINESS OBJECTS PRODUCT LICENSE FEES PAID BY LICENSEE TO BUSINESS OBJECTS FOR THE BUSINESS OBJECTS PRODUCT OR THE FEES PAID BY LICENSEE TO BUSINESS OBJECTS FOR THE SERVICE DIRECTLY CAUSING THE DAMAGES. IN NO EVENT SHALL YOU RAISE ANY CLAIM UNDER THIS ADDENDUM MORE THAN TWO YEARS AFTER: (i)THE DISCOVERY OF THE CIRCUMSTANCES GIVING RISE TO SUCH CLAIM; OR (ii) THE EFFECTIVE DATE OF THE TERMINATION OF THIS ADDENDUM. |
13. | TERM AND TERMINATION. The Product licenses granted hereunder shall be perpetual; provided however, Business Objects or OEM may immediately terminate this Addendum and any licenses provided hereunder if: (i) Business Objects or OEM notifies Licensee in writing of a breach and such breach is not cured within thirty (30) days; or (ii) |
2
Licensee makes an assignment for the benefit of creditors or proceedings are commenced by or for Licensee under any bankruptcy, insolvency, or debtors relief law. Termination shall not relieve Licensee from its obligation to pay fees that remain unpaid and shall not limit either party from pursuing other available remedies. Upon termination of this Addendum by Business Objects or OEM, neither Business Objects nor OEM shall have any obligation to refund to Licensee any fees paid by Licensee, and Licensee agrees to waive, in perpetuity and unconditionally, any and all claims for refunds. If a Product license is terminated by Business Objects or OEM, Licensee must certify in writing to Business Objects or OEM that Licensee has immediately un-installed and destroyed all copies of the Product within thirty (30) days of such revocation/expiration. Additionally, You may terminate this Addendum at any time by destroying the Products together with all copies in any form. The following Sections survive termination of this Addendum: 10 (last sentence only), 11, 12. |
14. | Government Rights. The Products shall be deemed commercial computer software and commercial computer software documentation pursuant to DFAR Section  ###-###-#### and FAR Section 12.212 (and any successor sections). The use of the Product including, but not limited to, its reproduction and display, by the United States of America and/or any of its instrumentalities, regardless of form (collectively Government), shall be governed by this Agreement. Under no circumstances shall Business Objects be obligated to comply with any Government requirements regarding cost or pricing data or cost accounting requirements. For any Licensee use of the Products that would require compliance by Business Objects with such Government requirements or in any manner affect Business Objects rights in the Products, Licensee must notify Business Objects of said Government requirement and obtain a waiver or exemption from such requirements for the benefit of Business Objects before any Government access to the Products. |
15. | License Types: |
15,1 | Definitions. Deployment means a single installation of no more than one of the following Product modules: Repository, Security Domain, Central Management Server (CMS) or CMS Cluster. |
15.2 | Named User License (NUL). When the Product is licensed on a Named User basis, each individual Named User must be specifically identified as the sole holder of a NUL. The sharing of the NUL by more than one individual is expressly prohibited. In addition, NUL(s) may not be transferred from one individual to another unless the original end user no longer requires, and is no longer permitted, access to the Product. NUL(s) for Business Objects Enterprise, Crystal Enterprise and Add-Ons are assigned to a single Deployment, and may not be shared among different Deployments. |
15.3 | Concurrent Access License (CAL). When the Product is licensed on a Concurrent Access basis, the aggregate number of end users accessing the Product at any one time may not exceed the number of CALs Licensee has obtained. CAL(s) are assigned to a particular Deployment, and may not be shared among different Deployments. When using CALs, Licensee may not utilize a program or system to cache or queue report requests. |
15.4 | Processor License. When the Product is licensed on a Processor basis the aggregate number of central processing units (Processors) running any Product components(s) (except, as to Crystal Enterprise, the Web Connector, SDK, Report Publishing Wizard and report viewers) may not exceed the number of Processors licensed. A multi-core chip Processor with N processor cores shall be counted as N Processors. |
15.5 | Server License (Data Integration products only). When the Product is licensed on a Server basis, the Product may be loaded onto a single computer with up to four (4) processors. |
16. | Product Specific Use Rights: |
16.1 | Performance Management Application Modules/Solutions and Dashboard Manager. The software components, tools and utilities supplied with an Performance Management Application Module, Performance Management Application Solution or Dashboard Manager may only be used with the product with which they were provided. In addition, the Web Intelligence utilities provided with Dashboard Manager may only be used to view the analytic templates provided with Dashboard Manager. |
16.2 | BusinessObjects Enterprise and Crystal Enterprise. Licensee may not combine licenses for different editions of BusinessObjects Enterprise or Crystal Enterprise in a single Deployment, (for example, Premium licenses may not be combined with Professional licenses in a single Deployment). Licensee may use BusinessObjects Professional and Crystal Enterprise Professional to publish and distribute only one of Business Objects proprietary report format types (Crystal Reports, OLAP Intelligence/Crystal Analysis, Web Intelligence/Desktop Intelligence or BusinessObjects). Web Intelligence and Desktop Intelligence are deemed a single proprietary report format for this purpose. If Licensee wishes to publish and distribute more than one report format type, Licensee must acquire BusinessObjects Enterprise Premium or Crystal Enterprise Premium. Notwithstanding the foregoing, if Licensee migrates from a combined BusinessObjects and WebIntelligence Deployment to BusinessObjects Enterprise Professional, Licensee may use both BusinessObjects and WebIntelligence report types in that Deployment. |
16.3 | BusinessObjects Enterprise Professional and Crystal Enterprise Professional Options. BusinessObjects Enterprise Professional Options and Crystal Enterprise Professional Options are licensed as add-ons to a Deployment. Options include Crystal Reports Explorer, Auditing, Publishing, Live Office, Integration Kits for third party applications and other products designated as BusinessObjects Enterprise or Crystal Enterprise Options. The number and type of Option licenses must match the number and type of BusinessObjects Enterprise or Crystal Enterprise licenses in the Deployment in which the Options are used. |
3
16.4 | Web Intelligence Interactive Viewing. Keycodes to Web Intelligence Interactive Viewing may unlock all features of the full Web Intelligence product. However, Web Intelligence Interactive Viewing is a limited license and may not be utilized to edit or create documents. |
16.5 | BusinessObjects Rapid Marts. When licensing BusinessObjects Rapid Marts, a license for BusinessObjects Data Integrator must also be obtained. If BusinessObjects Rapid Marts Product are licensed with the BusinessObjects Data Integrator, an individual BusinessObjects Rapid Marts license must be obtained for each BusinessObjects Data Integrator license. Copying one BusinessObjects Rapid Marts license and then deploying it to other instances is prohibited. In addition to the foregoing, Licensee must license certain applicable application interfaces. |
16.6 | BusinessObjects Data Integrator. If Licensee desires to deploy a Server license to access enterprise data sources such as packaged applications, mainframes, or technology infrastructure products (Enterprise Data Sources), Licensee must obtain individual BusinessObjects Data Integrator Interface licenses. |
16.6 | BusinessObjects Data Integrator Interfaces. When licensing the BusinessObjects Data Integrator Interfaces, licenses for BusinessObjects Data Integrator must also be obtained. An individual interface license must be acquired for each BusinessObjects Data Integrator license. If multiple instances of an Application, Technology, or Mainframe type are accessed by the BusinessObjects Data Integrator Interface, then one interface license must be acquired for each instance. If multiple instances of a Database type are accessed by the BusinessObjects Data Integrator Interface, then only one interface license must be acquired for that Database type. Unlike other Interfaces, Database interfaces are charged per database type and not per instance. |
16.7 | BusinessObjects Knowledge Accelerator. BusinessObjects Knowledge Accelerator may be used to meet Licensees employee training needs for the number of employees identified to Business Objects (Employees) and may not be used by or on behalf of any third party. Licensee shall purchase additional licenses equal to the number of additional or new Employees to be trained. Any customization tools included with the BusinessObjects Knowledge Accelerator Product (RWD Info Pak Simulator, Publisher, Web Architect and/or Global KnowledgeTM OnDemand-for-Business Objects Software) shall be used only for modifying or customizing the content developed by BusinessObjects Knowledge Accelerator Product, and only by the number of instructional designers and administrators specified in the sales order. Licensee shall not modify, reverse engineer, or distribute for commercial or non-commercial use such tools, or use such tools to develop other content, including content related to other Business Objects products. . Notwithstanding any other provision of this Agreement, NULs of Knowledge Accelerator may not be transferred to other individuals, even if the original user is no longer permitted access to Knowledge Accelerator. |
16.8 | BusinessObjects Publisher. BusinessObjects Publisher may be licensed on a: 1) Processor basis, or 2) Named User basis, where each recipient of a report generated by BusinessObjects Publisher must have a Named User license. |
16.9 | Crystal Reports Professional and Developer. |
16.9.1 | Designer Tools. The Crystal Reports report design application and utilities installed by the Crystal Reports setup program (Designer Tools) are licensed on a Named User basis. Each copy of Crystal Reports Professional, Crystal Reports Developer and Crystal Reports Server includes one Named User license of the Designer Tools. |
16.9.2 | Crystal Reports Developer Runtime Product (Applicable to Crystal Reports Developer Only). |
16.9.2.1 | Definitions Applicable to Crystal Reports Developer. |
Client Application means an application developed by Licensee that a) utilizes the Runtime Product, b) is installed fully on an end users machine, with all report processing local to that machine, and c) adds significant and primary functionality to the Runtime Product.
Internal Installation or Internally Install means installing into production Client Applications and/or Server Applications on one or more computers within Licensees company or organization only in connection with Licensees internal business purposes.
Distribution or Distribute means selling, leasing, licensing or redistributing Client Applications and/or Server Applications to third party end users external to Licensees company or organization.
Runtime Product means the version specific files and application program interfaces (APIs) specified in the RUNTIME.TXT file provided with the Product.
4
Server Application means an application developed by Licensee that a) utilizes the Runtime Product, b) allows more than one user to access the Runtime Product either directly or indirectly through any middle tier application(s), and c) adds significant and primary functionality to the Runtime Product. A Client Application installed in a Windows terminal server environment (e.g. Citrix or Microsoft Remote Desktop Platform) is a Server Application.
16.9.2.2 | Use of the Runtime Product. Licensee may install and use a single copy of the Runtime Product to develop Client Applications and Server Applications. The Distribution and Internal Installation terms and conditions differ based on the type of applications Licensee develops, as described in the following sections. |
16.9.2.3 | Internal Installation of Client Applications and Server Applications. Business Objects grants Licensee a personal, nonexclusive, limited license to Internally Install the Runtime Product with Client Applications and Server Applications. |
16.9.2.4 | Distribution of Client Applications. Business Objects grants Licensee a personal, nonexclusive, limited license to Distribute Client Applications to end users, if Licensee complies with all of the terms herein, including without limitation section 16.9.2.6. If Licensee Distributes Client Applications utilizing the Report Creation API (RCAPI), Licensee must also acquire a licensed copy of Crystal Reports Developer for each third party to whom the Client Application is distributed. |
16.9.2.5 | Distribution of Server Applications. Business Objects grants Licensee a personal, nonexclusive limited license to Distribute Server Applications to third parties provided that a) Licensee has acquired a licensed copy of Crystal Reports Develop for each third party to whom Licensee distributes a Server Application, and b) Licensee complies with all of the terms of such license and this license agreement, including without limitation section 16.9.2.6. |
16.9.2.6 | Runtime Product Distribution Requirements. If Licensee Distributes the Runtime Product to third parties pursuant to sections 16.9.2.4 or 16.9.2.5, Licensee shall comply with the following requirements: |
(a) Licensee Distributes copies of the Runtime Product solely as a part of an application that adds specific and primary functionality to the Runtime Product;
(b) Licensee remains solely responsible for support, service, upgrades, and technical or other assistance, required or requested by anyone receiving such Runtime Product copies or sample applications;
(c) Licensee does not use the name, logo, or trademark of Business Objects, or the Product, without prior written permission from Business Objects;
(d) Licensee will defend, indemnify and hold Business Objects harmless against any claims or liabilities arising out of the use, reproduction or distribution of Runtime Product or the associated application;
(e) Licensee shall not distribute the Runtime Product with any general-purpose report writing, data analysis or report delivery product or any other product that performs the same or similar functions as Business Objects product offerings; and
(f) Licensee shall secure the end users (End User) consent to terms substantially similar to the following:
End User agrees not to modify, disassemble, decompile, translate, adapt or reverse-engineer the Runtime Product or the report file (.RPT) format;
End User agrees not to distribute the Runtime Product to any third party;
End User agrees not to use the Runtime Product to create for distribution a product that is generally competitive with Business Objects product offerings;
End User agrees not to use the Runtime Product to create for distribution a product that converts the report file (.RPT) format to an alternative report file format used by any general-purpose report writing, data analysis or report delivery product that is not the property of Business Objects;
End User agrees not to use the Product on a rental or timesharing basis or to operate a service bureau facility for the benefit of third-parties;
BUSINESS OBJECTS AND ITS SUPPLIERS DISCLAIM ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NONINFRINGEMENT OF THIRD PARTY RIGHTS. BUSINESS OBJECTS AND ITS SUPPLIERS SHALL HAVE NO LIABILITY WHATSOEVER FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE, COVER OR OTHER DAMAGES ARISING UNDER THIS AGREEMENT OR IN CONNECTION WITH THE SOFTWARE.
16.10 | Crystal Reports Server. Crystal Reports Server may be offered on a Named User or CAL basis., Regardless of the license type, for each Deployment Crystal Reports Server may be installed and used only on a single server that has no more than four Processors, If licensed on a CAL basis, no more than 20 CALs may be used in each Deployment. Furthermore, there may be no more than one instance of each Enterprise Server in a deployment. An Enterprise Server includes the Central Management Server (CMS), Crystal |
5
Reports Page Server, Crystal Reports Cache Server, Crystal Reports Job Server, Input File Repository, Output File Repository, Destination Job Server, Program Job Server, Event Server, List of Values Job Server, Report Application Server and any other server designated as an Enterprise Server in the Documentation. You may not create or modify universes using the universe designer components, if any, included with Crystal Reports Server. If bundled with Crystal Reports Professional or Developer, Crystal Reports Server is licensed on a Promotional License basis. |
6
CPT ADDENDUM
1. | This sublicense grants You the limited right, subject to the terms of this Addendum, to use content from the American Medical Associations (AMA) ASCII or EBCDIC data file of Physicians Current Procedural Terminology published by the AMA in the English language as used in the United States, a coding work of nomenclature and codes for reporting of healthcare services (CPT Codes) solely with the Epic Program Property that You have licensed from Epic as set forth in Exhibit 1(a) to Epics Standard License and Support Agreement with You (the Agreement). |
2. | Your use of the CPT Codes under this sublicense is for non-production (e.g. training and testing) uses of the Program Property only. You agree that you will obtain a license directly from the AMA to use the CPT Codes with the Program Property for production purposes. |
3. | Your use of the CPT Codes under this sublicense is also limited to the number of users specified in the Epic standard license agreement (see comments section in Exhibit 1(a) for the licensed user level). If You wish to allow additional users to use the CPT Codes (beyond those specified in Exhibit 1(a) for non-production purposes), You may obtain a license for such additional users from Epic or the AMA. |
4. | You acknowledge and understand that Epics right to obtain updated versions of the CPT Codes for non-production purposes is dependent upon Epics continued contractual relationship with the AMA and that the price for such updated versions is subject to change. You further acknowledge and understand that You must obtain all updated versions of the CPT Codes for production uses with the Program Property directly from the AMA. |
5. | This sublicense is nontransferable, nonexclusive, and for the sole purpose of internal use of You in the English language within the United States and its territories. |
6. | You may not publish, distribute via the Internet or other public computer based information system, create derivative works (including translations), transfer, sell, lease, license, or otherwise make available to any unauthorized party the CPT Codes, or a copy or portion of the Editorial Content. |
7. | You may only make copies of the Program Property containing Epic-provided CPT Codes for back up or archival purposes. The CPT Codes are copyrighted by the AMA. CPT is a registered trademark of the AMA. All notices of the AMAs proprietary rights, including its trademark and copyright notices, must appear on all permitted copies. |
8. | You agree to ensure that anyone who has authorized access to the Program Property containing the CPT Codes complies with the terms of this Addendum. |
9. | TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE CPT CODES AS CONTAINED IN THE PROGRAM PROPERTY ARE PROVIDED BY THE AMA AND EPIC AS IS WITHOUT ANY WARRANTY WHATSOEVER. ALL WARRANTIES, WHETHER EXPRESS OR IMPLIED, ARE DISCLAIMED BY THE AMA AND EPIC, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF MERCHANTABILITY, TITLE, ACCURACY, NONINFRINGEMENT, FITNESS FOR A PARTICULAR PURPOSE, AND ANY IMPLIED WARRANTY AGAINST INTERFERENCE WITH YOUR ENJOYMENT OF THE PROGRAM PROPERTY OR THE CPT CODES OR AGAINST INFRINGEMENT. YOU ACKNOWLEDGE THAT NO EMPLOYEE OF EPIC OR ANY OTHER PARTY IS AUTHORIZED TO MAKE ANY REPRESENTATIONS OR WARRANTIES REGARDING THE CPT CODES. THE CPT CODES ARE PROVIDED WITHOUT ANY LIABILITY TO THE AMA OR EPIC. THE AMA AND EPIC SHALL NOT BE LIABLE, WITHOUT LIMITATION, FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR SPECIAL DAMAGES OR LOST PROFITS. THE AMAS SOLE RESPONSIBILITY CONCERNING THE CPT CODES IS TO MAKE AVAILABLE TO EPIC RPLACEMENT COPIES OF THE CPT CODES IF THE CPT CODES ARE NOT INTACT. EPIC AND THE AMA DISCLAIM ANY LIABILITY FOR ANY CONSEQUENCE DUE TO USE, MISUSE, OR INTERPRETATION OF INFORMATION CONTAINED OR NOT CONTAINED IN THE CPT CODES. THIS PROVISION SHALL SURVIVE TERMINATION OF THE AGREEMENT AND THIS CPT ADDENDUM. |
10. | This sublicense will terminate if you are in default of Your obligations under this Addendum, and may be terminated upon written notice to You by Epic if You are in default of Your obligations under the Agreement. |
11. | The provisions of this sublicense shall be considered as severable, so that in the event a provision is determined to violate any law or is unenforceable the remainder of the provisions will remain in full force and effect. |
12. | U.S. Government Rights. This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable, which was developed exclusively at private expense by the American Medical Association, 515 North Lake St., Chicago, IL 60654. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS ###-###-####(b)(2) (November 1995) and/or subject to the restrictions of DFARS ###-###-####-1(a) (June 1995) and DFARS ###-###-####-3(a) (June 1995), as applicable, for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (December 2007) and/or subject to the restricted rights provisions of FAR 52.227-14 (December 2007) and FAR 52.227-19 (December 2007), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal Procurements. |
1
If Your use of Epic Program Property includes the ability to access such Program Property containing the CPT Codes via the Internet, then the following shall also apply:
13. | You agree to use user registration technology, that is, application-level security as well as through the single-user password response security software for such Internet use of the Program Property containing the CPT Codes. |
14. | You will maintain appropriate procedures and technology to track the number of users and maintain server logs for audit purposes for three years following the year to which they pertain. |
15. | You agree to use firewall technology, such that the Program Property is behind a firewall that filters access and prevents unauthorized retrieval of Program Property containing the CPT Codes. |
16. | You agree to limit access to users of the CPT Codes to users in the United States. |
2
DR. SCHMITT PEDIATRIC CONTENT ADDENDUM
The Pediatric Content (hereafter defined) provided and sublicensed to AHS Management Company, Inc. (You) by Epic Systems Corporation (Epic) is owned by Barton D. Schmitt, M.D. (Dr. Schmitt). Before using the Pediatric Content, You should carefully read the following terms and conditions, which apply to the sublicense of the Pediatric Content from Epic to You, as authorized by Dr. Schmitt. Your use of the Pediatric Content indicates Your acceptance of these terms and conditions.
1. | DEFINITIONS |
Any capitalized terms used herein that are not defined in this Dr. Schmitt Pediatric Content Addendum (Addendum) but are defined in the License and Support Agreement between You and Epic (Agreement) shall have the meaning given to such terms in the Agreement.
(A) | Documentation shall mean instructions, manuals or other materials relating to the Pediatric Content that Dr. Schmitt makes available to his customers and/or licensees. |
(B) | Pediatric Content shall mean Dr. Schmitts electronic data files of pediatric content (including without limitation all data contained therein) that are further described in the attached Exhibit A to this Addendum. |
(C) | Update means a new release or version of the Pediatric Content that contains any new or updated data, including without limitation corrections, expansions and enhancements to the Pediatric Content made by Dr. Schmitt. Updates will include the new release or version of the Pediatric Content and its associated Documentation. |
2. | GRANT OF ACCESS RIGHTS, COPYRIGHT AND RESTRICTIONS |
(A) | TEMPORARY TRIAL ACCESS |
You are hereby granted a temporary, nonexclusive, non-transferable and limited trial license (Trial License) to access and use the Pediatric Content only in connection with the Epic Program Property and to access and use the Documentation in connection with the Pediatric Content. The Trial License is granted for the sole purpose of permitting You to evaluate the Pediatric Content to determine whether You wish to subscribe for the Pediatric Content under a Subscription (hereafter defined). This Addendum and all applicable terms of the Agreement will apply to the Trial License granted under this Section 2(A) except payment, term and maintenance terms. You will not be obligated to pay any license, subscription or other fees to Epic unless or until the Trial License is converted to a Subscription under this Section 2(A).
The term of the Trial License begins upon delivery of the Pediatric Content to You and terminates on the later of (i) the date that You first begin live, production use of the Epic software that uses the Pediatric Content to process actual patient data or (ii) three (3) months after Epic has delivered the Pediatric Content to You (the Trial License Period) (the later to occur of the dates indicated in (i) or (ii) is referred to as the Conversion Date). The Trial License will also terminate automatically prior to the Conversion Date upon any non-compliance by You with any term or condition governing the Trial License or upon Your written notification to Epic that You do not wish to convert Your Trial License to a Subscription.
You must notify Epic in writing prior to the end of the Trial License Period if You do not wish to convert Your Trial License to a Subscription. In such event, You agree to either immediately return all copies of the Pediatric Content to Epic or immediately delete all copies of the Pediatric Content then in Your possession and warrant to Epic that You have done so. If You do not provide Epic before expiration of the Trial License with both (1) notice of termination of the Trial License and (2) either return of the Pediatric Content or Your warrant that You have deleted the Pediatric Content, then Your Trial License will automatically convert to a Subscription governed by the same terms and conditions as if You had elected to convert the Trial License, including but not limited to the payment of all fees due hereunder.
(B) | GENERAL SUBSCRIPTION TERMS |
Upon conversion of the Trial License to a Subscription on the Conversion Date, You will be granted a non-exclusive, non-transferable subscription (Subscription) to access and use the Pediatric Content only in connection with the Epic Program Property, and to access and use the Documentation only in connection with the Pediatric Content, all subject to the terms and restrictions provided in this Addendum (other than terms in Section 2(A) solely applicable to the Trial License) and all applicable terms of the Agreement.
You may provide access to and the right to use the Pediatric Content and the Documentation to any person or entity who is permitted to have access to and the right to use the Epic Program Property under the Agreement and subject to the same limitations.
1
The initial annual subscription fees for the Subscription shall be due and payable on the Conversion Date, and subsequent annual subscription fee payments shall be due thirty (30) days prior to each anniversary of the Conversion Date. Epic may adjust the annual subscription fees from time to time.
(C) | OBLIGATIONS UPON TERMINATION |
If for any reason the Agreement or the Subscription is terminated (or the Trial License is terminated other than by conversion to a Subscription), You shall immediately delete all copies of the Pediatric Content then in Your possession and warrant to Epic that You have done so. The terms of Section 3 and Sections 5 through 9 of this Addendum shall survive termination of the Agreement, the Trial License or the Subscription.
3. | OWNERSHIP AND PROPRIETARY RIGHTS |
Dr. Schmitt retains ownership of all rights in the Pediatric Content and of all proprietary technology embodied therein. The Pediatric Content shall at all times remain the property of Dr. Schmitt, and You shall have no right, title or interest therein, except as expressly provided by this Addendum.
You may modify the Pediatric Content (including modifications to format and storage media) in order to more efficiently use the Pediatric Content. In the event of modification: (i) You shall assume full responsibility for any such new or modified content; (ii) You will maintain all copyright notices for the Pediatric Content as required below in Section 3; and (iii) Dr. Schmitt shall retain ownership of all copyrights and other intellectual property in the Pediatric Content.
You understand and acknowledge that Dr. Schmitts rights of literary property and copyright in the Pediatric Content are reserved and retained by Dr. Schmitt at all times. You agree not to remove or destroy any copyright notices, confidentiality legends or proprietary markings placed upon or contained within the Pediatric Content. You may apply private labels to the names of the data sets that comprise the Pediatric Content, but in each case You shall provide prominent credit to Dr. Schmitt as the author of the Pediatric Content in all written materials used to market or advertise any materials, goods, services, operations (including web pages or sites on the World Wide Web) or other items that contain all or a portion of the Pediatric Content. You may also refer to the Pediatric Content by the descriptive names set forth in Exhibit A.
4. | MAINTENANCE |
The maintenance program for the Pediatric Content is included with Your annual subscription fee and begins on the Conversion Date. Maintenance includes telephone consultation and assistance regarding the Pediatric Content during Epics regular business hours and any Updates for the Pediatric Content subscribed for by You that are received by Epic for distribution to sublicensees of the Pediatric Content. You agree to submit all questions, requests for assistance and feedback regarding the Pediatric Content to Epic, and not directly to Dr. Schmitt or his agents. Epic will discuss Your questions, requests and feedback with Dr. Schmitt and provide such support to You as is appropriate and in accordance with Epics agreement with Dr. Schmitt, and may forward Your questions or refer You to Dr. Schmitt or his agents.
5. | USE OF THE PEDIATRIC CONTENT |
You represent and warrant that no portion of the Pediatric Content will be used in any way by You or any of Your employees or agents unless that portion has been reviewed, amended as necessary and approved by a medical director or medical advisory panel who or which You have designated as responsible for overseeing its use. You further represent and warrant that You will not use the Pediatric Content in the State of Colorado. It is Your responsibility to keep the Pediatric Content up to date. Use of the Pediatric Content requires the intellect and judgment of the user. With the exception of the Parent Care/Parent Triage Guidelines and Parent Advice Topics, which might be included in the Pediatric Content (see Exhibit A to this Addendum to determine if these content sets are included in the Pediatric Content subscribed for by You), the Pediatric Content is most suitable for use by physicians and nurse practitioners. Nurses and physician assistants should receive training before using the Pediatric Content, and non-licensed and non-health professionals (for example, secretaries) should not use the Pediatric Content.
6. | DISCLAIMERS |
THE PEDIATRIC CONTENT IS BEING PROVIDED AND IN EACH CASE SHALL BE PROVIDED TO YOU STRICTLY AS IS WITHOUT WARRANTY OF ANY KIND. UNDER NO CIRCUMSTANCES SHALL EPIC OR DR. SCHMITT BE RESPONSIBLE FOR THE ACCURACY, SAFETY, EFFICACY OR COMPLETENESS OF THE PEDIATRIC CONTENT. NEITHER EPIC NOR DR. SCHMITT MAKES ANY REPRESENTATIONS OR WARRANTIES (EXPRESS OR IMPLIED) PURSUANT TO THIS ADDENDUM AND EPIC AND DR. SCHMITT EACH DISCLAIM ANY WARRANTIES WITH RESPECT TO THE PEDIATRIC CONTENT,
2
INCLUDING WITHOUT LIMITATION ANY EXPRESS OR IMPLIED WARRANTIES OF TITLE, ACCURACY, NON-INFRINGEMENT, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR ANY IMPLIED WARRANTY AGAINST INTERFERENCE WITH YOUR ENJOYMENT OF THE PROGRAM PROPERTY OR THE PEDIATRIC CONTENT. YOU ACKNOWLEDGE THAT NO EMPLOYEE OF EPIC OR ANY OTHER PARTY IS AUTHORIZED TO MAKE ANY REPRESENTATIONS OR WARRANTY NOT IN THIS AGREEMENT. EPIC AND DR. SCHMITT EACH DISCLAIM ANY RESPONSIBILITY FOR ANY HARMFUL CONSEQUENCE, LOSS, INJURY OR DAMAGE ASSOCIATED WITH THE USE AND APPLICATION OF INFORMATION OR ADVICE CONTAINED IN THE PEDIATRIC CONTENT.
7. | LIMITATION OF LIABILITY |
IN NO EVENT SHALL DR. SCHMITT OR ANY OF HIS SUPPLIERS OR AGENTS BE LIABLE FOR ANY CONSEQUENTIAL, SPECIAL OR INCIDENTAL DAMAGES WHATSOEVER (INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF BUSINESS PROFITS, BUSINESS INTERRUPTION, OR LOSS OF BUSINESS INFORMATION) ARISING OUT OF THE USE OR INABILITY TO USE THE PEDIATRIC CONTENT, EVEN IF DR. SCHMITT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
EPIC SHALL HAVE NO LIABILITY WHATSOEVER ARISING OUT OF THE PEDIATRIC CONTENT OR USE OF THE PEDIATRIC CONTENT, AND YOU HEREBY AGREE TO WAIVE ANY AND ALL CLAIMS THAT YOU MAY HAVE AGAINST EPIC ASSOCIATED WITH THE PEDIATRIC CONTENT OR USE OF THE PEDIATRIC CONTENT, EVEN IF EPIC HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH CLAIMS OR DAMAGES.
8. | THIRD PARTY BENEFICIARY |
Dr. Schmitt is an intended third-party beneficiary to this Addendum. Provisions of this Addendum are made expressly for the benefit of Dr. Schmitt and are enforceable by both Epic and Dr. Schmitt. Any unauthorized transfer or disclosure of the Pediatric Content not otherwise permitted under this Addendum may cause great harm to Dr. Schmitt, and You agree that in such event Dr. Schmitt or Epic shall have a right to injunctive relief from a court of competent jurisdiction.
9. | MISCELLANEOUS |
This Addendum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without giving effect to its conflict of laws principles, and any action (whether by alternative dispute resolution or in court) arising under this Addendum shall be brought exclusively in Wisconsin. You and Epic consent to the personal jurisdiction of the state and federal courts located in Wisconsin.
The provisions of this Addendum shall be considered as severable, so that the invalidity or unenforceability of any provisions will not affect the validity or enforceability of the remaining provisions; provided that no such severability shall be effective if it materially changes the economic benefit of this Addendum to either party.
The terms and conditions in the Agreement and this Addendum state the entire agreement with You relating to the Pediatric Content, and supersede any prior agreement, whether written or oral, relating to the subject matter hereof.
3
EXHIBIT A
Product 1: Pediatric Telephone Triage Algorithms After Hours Version
1. | Description. Professional version written for use in call centers by nurses to manage After Hours telephone triage calls for providers or payors. |
2. | Associated Deliverables: then-available topics (currently 316 topics) |
| Professional version written for physicians and nurses |
| Dispositions, questions and care advice can be customized |
3. | Licensor services shall include: |
| Providing current and complete version of clinical content in a Microsoft Access database |
| Providing updates on existing topics and several new topics on a yearly basis |
| Providing urgent updates on a timely basis |
| Remaining available to the medical director and/or nursing director or other designated person of Epic for any questions about the medical content of the protocols. |
4
Product 2: Pediatric Telephone Triage Protocols Office Hours Version
1. | Description. Designed for use in call centers, physician practices, or clinics during daytime (office) hours. |
2. | Associated Deliverables: then-available topics (currently 225 topics) |
| Currently available in physician offices in book format (Publisher: American Academy of Pediatrics). |
3. | Licensor services shall include: |
| Providing current and complete version of clinical content in Microsoft Access database |
| Providing updates on existing topics on a yearly basis |
| Providing urgent updates on a timely basis |
| Remaining available to the medical director and/or nursing director or other designed person of Epic for any questions about the medical content of the protocols. |
5
DR. THOMPSON ADULT MEDICAL CONTENT ADDENDUM
The Adult Medical Content (hereafter defined) provided and sublicensed to AHS Management Company, Inc. (You) by Epic Systems Corporation (Epic) is owned by David A. Thompson, M.D. (Dr. Thompson). Before using the Adult Medical Content, You should carefully read the following terms and conditions, which apply to the sublicense of the Adult Medical Content from Epic to You, as authorized by Dr. Thompson. Your use of the Adult Medical Content indicates Your acceptance of these terms and conditions.
1. | DEFINITIONS |
Any capitalized terms used herein that are not defined in this Dr. Thompson Adult Medical Content Addendum (Addendum) but are defined in the License and Support Agreement between You and Epic (Agreement) shall have the meaning given to such terms in the Agreement.
(A) | Documentation shall mean instructions, manuals or other materials relating to the Adult Medical Content that Dr. Thompson makes available to his customers and/or licensees. |
(B) | Adult Medical Content shall mean Dr. Thompsons electronic data files of adult medical content (including without limitation all data contained therein) that are further described in the attached Exhibit A to this Addendum. |
(C) | Update means a new release or version of the Adult Medical Content that contains any new or updated data, including without limitation corrections, expansions and enhancements to the Adult Medical Content made by Dr. Thompson. Updates will include the new release or version of the Adult Medical Content and its associated Documentation. |
2. | GRANT OF ACCESS RIGHTS, COPYRIGHT AND RESTRICTIONS |
(A) | TEMPORARY TRIAL ACCESS |
You are hereby granted a temporary, nonexclusive, non-transferable and limited trial license (Trial License) to access and use the Adult Medical Content only in connection with the Epic Program Property and to access and use the Documentation in connection with the Adult Medical Content. The Trial License is granted for the sole purpose of permitting You to evaluate the Adult Medical Content to determine whether You wish to subscribe for the Adult Medical Content under a Subscription (hereafter defined). This Addendum and all applicable terms of the Agreement will apply to the Trial License granted under this Section 2(A) except payment, term and maintenance terms. You will not be obligated to pay any license, subscription or other fees to Epic unless or until the Trial License is converted to a Subscription under this Section 2(A).
The term of the Trial License begins upon delivery of the Adult Medical Content to You and terminates on the later of (i) the date that You first begin live, production use of the Epic software that uses the Adult Medical Content to process actual patient data or (ii) three (3) months after Epic has delivered the Adult Medical Content to You (the Trial License Period) (the later to occur of the dates indicated in (i) and (ii) is referred to as the Conversion Date). The Trial License will also terminate automatically prior to the Conversion Date upon any non-compliance by You with any term or condition governing the Trial License or upon Your written notification to Epic that You do not wish to convert Your Trial License to a Subscription.
You must notify Epic in writing prior to the end of the Trial License Period if You do not wish to convert Your Trial License to a Subscription. In such event, You agree to either immediately return all copies of the Adult Medical Content to Epic or immediately delete all copies of the Adult Medical Content then in Your possession and warrant to Epic that You have done so. If You do not provide Epic before expiration of the Trial License with both (1) notice of termination of the Trial License and (2) either return of the Adult Medical Content or Your warrant that You have deleted the Adult Medical Content, then Your Trial License will automatically convert to a Subscription governed by the same terms and conditions as if You had elected to convert the Trial License, including but not limited to the payment of all fees due hereunder.
(B) | GENERAL SUBSCRIPTION TERMS |
Upon conversion of the Trial License to a Subscription on the Conversion Date, You will be granted a non-exclusive, non-transferable subscription (Subscription) to access and use the Adult Medical Content only in connection with the Epic Program Property, and to access and use the Documentation only in connection with the Adult Medical Content, all subject to the terms and restrictions provided in this Addendum (other than terms in Section 2(A) solely applicable to the Trial License) and all applicable terms of the Agreement. You may provide access to and the right to use the Adult Medical Content and the Documentation to any person or entity who is permitted to have access to and the right to use the Epic Program Property under the Agreement and subject to the same limitations.
1
The initial annual subscription fees for the Subscription shall be due and payable on the Conversion Date, and subsequent annual subscription fee payments shall be due thirty (30) days prior to each anniversary of the Conversion Date. Epic may adjust the annual subscription fees from time to time.
(c) | OBLIGATIONS UPON TERMINATION |
If for any reason the Agreement or the Subscription is terminated (or the Trial License is terminated other than by conversion to a Subscription), You shall immediately delete all copies of the Adult Medical Content then in Your possession and warrant to Epic that You have done so. The terms of Section 3 and Sections 5 through 9 of this Addendum shall survive termination of the Agreement, the Trial License or the Subscription.
3. | OWNERSHIP AND PROPRIETARY RIGHTS |
Dr. Thompson retains ownership of all rights in the Adult Medical Content and of all proprietary technology embodied therein. The Adult Medical Content shall at all times remain the property of Dr. Thompson, and You shall have no right, title or interest therein, except as expressly provided by this Addendum.
You may modify the Adult Medical Content (including modifications to format and storage media) in order to more efficiently use the Adult Medical Content. In the event of modification: (i) You shall assume full responsibility for any such new or modified content; (ii) You will maintain all copyright notices for the Adult Medical Content as required below in Section 3; and (iii) Dr. Thompson shall retain ownership of all copyrights and other intellectual property in the Adult Medical Content.
You understand and acknowledge that Dr. Thompsons rights of literary property and copyright in the Adult Medical Content are reserved and retained by Dr. Thompson at all times. You agree not to remove or destroy any copyright notices, confidentiality legends or proprietary markings placed upon or contained within the Adult Medical Content. You may apply private labels to the names of the data sets that comprise the Adult Medical Content, but in each case You shall provide prominent credit to Dr. Thompson as the author of the Adult Medical Content in all written materials used to market or advertise any materials, goods, services, operations (including web pages or sites on the World Wide Web) or other items that contain all or a portion of the Adult Medical Content. You may also refer to the Adult Medical Content by the descriptive names set forth in Exhibit A.
4. | MAINTENANCE |
The maintenance program for the Adult Medical Content is included with Your annual subscription fee and begins on the Conversion Date. Maintenance includes telephone consultation and assistance regarding the Adult Medical Content during Epics regular business hours and any Updates for the Adult Medical Content subscribed for by You that are received by Epic for distribution to sublicensees of the Adult Medical Content. You agree to submit all questions, requests for assistance and feedback regarding the Adult Medical Content to Epic, and not directly to Dr. Thompson or his agents. Epic will discuss Your questions, requests and feedback with Dr. Thompson and provide such support to You as is appropriate and in accordance with Epics agreement with Dr. Thompson, and may forward Your questions or refer You to Dr. Thompson or his agents.
5. | USE OF THE ADULT MEDICAL CONTENT |
You represent and warrant that no portion of the Adult Medical Content will be used in any way by You or any of Your employees or agents unless that portion has been reviewed, amended as necessary and approved by a medical director or medical advisory panel who or which You have designated as responsible for overseeing its use. It is Your responsibility to keep the Adult Medical Content up to date. Use of the Adult Medical Content requires the intellect and judgment of the user. The Adult Medical Content is most suitable for use by physicians and nurse practitioners. Nurses and physician assistants should receive training before using the Adult Medical Content, and non-licensed and non-health professionals (for example, secretaries) should not use the Adult Medical Content.
2
6. | DISCLAIMERS |
THE ADULT MEDICAL CONTENT IS BEING PROVIDED AND IN EACH CASE SHALL BE PROVIDED TO YOU STRICTLY AS IS WITHOUT WARRANTY OF ANY KIND. UNDER NO CIRCUMSTANCES SHALL EPIC OR DR. THOMPSON BE RESPONSIBLE FOR THE ACCURACY, SAFETY, EFFICACY OR COMPLETENESS OF THE ADULT MEDICAL CONTENT. NEITHER EPIC NOR DR. THOMPSON MAKES ANY REPRESENTATIONS OR WARRANTIES (EXPRESS OR IMPLIED) PURSUANT TO THIS ADDENDUM AND EPIC AND DR. THOMPSON EACH DISCLAIM ANY WARRANTIES WITH RESPECT TO THE ADULT MEDICAL CONTENT, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OF TITLE, ACCURACY, NON-INFRINGEMENT, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR ANY IMPLIED WARRANTY AGAINST INTERFERENCE WITH YOUR ENJOYMENT OF THE PROGRAM PROEPRTY OR THE ADULT MEDICAL CONTENT. YOU ACKNOWLEDGE THAT NO EMPLOYEE OF EPIC OR ANY OTHER PARTY IS AUTHORIZED TO MAKE ANY REPRESENTATIONS OR WARRANTY NOT IN THIS AGREEMENT. EPIC AND DR. THOMPSON EACH DISCLAIM ANY RESPONSIBILITY FOR ANY HARMFUL CONSEQUENCE, LOSS, INJURY OR DAMAGE ASSOCIATED WITH THE USE AND APPLICATION OF INFORMATION OR ADVICE CONTAINED IN THE ADULT MEDICAL CONTENT.
7. | LIMITATION OF LIABILITY |
IN NO EVENT SHALL DR. THOMPSON OR ANY OF HIS SUPPLIERS OR AGENTS BE LIABLE FOR ANY CONSEQUENTIAL, SPECIAL OR INCIDENTAL DAMAGES WHATSOEVER (INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF BUSINESS PROFITS, BUSINESS INTERRUPTION, OR LOSS OF BUSINESS INFORMATION) ARISING OUT OF THE USE OR INABILITY TO USE THE ADULT MEDICAL CONTENT, EVEN IF DR. THOMPSON HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
EPIC SHALL HAVE NO LIABILITY WHATSOEVER ARISING OUT OF THE ADULT MEDICAL CONTENT OR USE OF THE ADULT MEDICAL CONTENT, AND YOU HEREBY AGREE TO WAIVE ANY AND ALL CLAIMS THAT YOU MAY HAVE AGAINST EPIC ASSOCIATED WITH THE ADULT MEDICAL CONTENT OR USE OF THE ADULT MEDICAL CONTENT, EVEN IF EPIC HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH CLAIMS OR DAMAGES.
8. | THIRD PARTY BENEFICIARY |
Dr. Thompson is an intended third-party beneficiary to this Addendum. Provisions of this Addendum are made expressly for the benefit of Dr. Thompson and are enforceable by both Epic and Dr. Thompson. Any unauthorized transfer or disclosure of the Adult Medical Content not otherwise permitted under this Addendum may cause great harm to Dr. Thompson, and You agree that in such event Dr. Thompson or Epic shall have a right to injunctive relief from a court of competent jurisdiction.
9. | MISCELLANEOUS |
This Addendum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without giving effect to its conflict of laws principles, and any action (whether by alternative dispute resolution or in court) arising under this Addendum shall be brought exclusively in Wisconsin. You and Epic consent to the personal jurisdiction of the state and federal courts located in Wisconsin.
The provisions of this Addendum shall be considered as severable, so that the invalidity or unenforceability of any provisions will not affect the validity or enforceability of the remaining provisions; provided that no such severability shall be effective if it materially changes the economic benefit of this Addendum to either party.
The terms and conditions in the Agreement and this Addendum state the entire agreement with You relating to the Adult Medical Content, and supersede any prior agreement, whether written or oral, relating to the subject matter hereof.
3
Exhibit A
Product 1: Adult Telephone Triage Algorithms After Hours Version
1. | Description. Professional version written for use in call centers by nurses to manage After Hours telephone triage calls for providers or payors. |
2. | Associated Deliverables: then-available topics (currently 326 topics) |
| Professional version written for physicians and nurses |
| Dispositions, questions and care advice can be customized |
3. | Licensor Services shall include: |
| Providing current and complete version of clinical content in a Microsoft Access database |
| Providing updates on existing topics and several new topics on a yearly basis |
| Providing urgent updates on a timely basis |
| Remaining available to the medical director and/or nursing director or other designated person of Epic for any questions about the medical content of the protocols. |
4
Product 2: Adult Telephone Triage Protocols Office Hours Version
1. | Description. Designed for use in call centers, physician practices, or clinics during daytime (office) hours. |
2. | Associated Deliverables: then-available topics (currently 161 topics) |
| Currently available in physician offices in book format (Publisher: American Academy of Pediatrics). |
3. | Licensor Services shall include: |
| Providing current and complete version of clinical content in Microsoft Access database |
| Providing updates on existing topics on a yearly basis |
| Providing urgent updates on a timely basis |
| Remaining available to the medical director and/or nursing director or other designed person of Epic for any questions about the medical content of the protocols. |
5
DIAGNOSTIC DATA ADDENDUM
The following provisions apply to the license to the Diagnostic Data software and data licensed under the Agreement.
1. | Software and Data Licensed. This Addendum covers the CodeSearch Tool provided by Diagnostic Data to Epic to the extent they are loaded into the Program Property delivered to You by Epic. |
2. | Limitations. Your use of the Diagnostic Data software and data shall be limited to the Licensed Volume specified on Exhibit 1(a) and shall be subject to the same restrictions as the Program Property. The American Dental Association codes (the 5-character alphanumeric procedure codes beginning with D) that are provided with the HCPCS file may only be used for purposes directly related to participation in the Medicare program. Permission for any other use must be obtained from the American Dental Association. |
3. | THE DIAGNOSTIC DATA SOFTWARE AND DATA IS PROVIDED TO YOU STRICTLY AS IS WITHOUT WARRANTY OF ANY KIND. EPIC AND DIAGNOSTIC DATA HEREBY DISCLAIM ANY AND ALL WARRANTIES OF ANY KIND OR NATURE PERTAINING OR RELATING TO THE DIAGNOSTIC DATA SOFTWARE OR DATA OR ANY PART THEREOF, WHETHER EXPRESS OR IMPLIED OR WRITTEN OR ORAL, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, ACCURACY, FITNESS FOR A PARTICULAR PURPOSE AND TITLE, AND ANY IMPLIED WARRANTY AGAINST INTERFERENCE WITH YOUR ENJOYMENT OF THE PROGRAM PROPERTY OR THE DIAGNOSTIC DATA SOFTWARE OR AGAINST INFRINGEMENT. YOU ACKNOWLEDGE THAT NO EMPLOYEE OF EPIC OR ANY OTHER PARTY IS AUTHORIZED TO MAKE ANY REPRESENTATIONS OR WARRANTY REGARDING THE DIAGNOSTIC DATA SOFTWARE. |
BI-RADS® ATLAS* ADDENDUM
The following provisions apply to the use of BI-RADS® ATLAS licensed under the Agreement.
I. | DEFINITIONS. |
BI-RADS® ATLAS means the Breast Imaging Reporting and Data System, Atlas data content owned and made available to Epic by American College of Radiology for sublicensing to You. BI-RADS® ATLAS is a quality assurance tool consisting of lexicons of standardized terminology, a reporting organization, assessment structure, coding system and data collection structure that are designed to standardize mammography, ultrasound and MRI reporting to assist in breast imaging interpretations and to facilitate outcome monitoring.
II. | LICENSE. |
You shall have a non-exclusive, non-transferable, right to use BI-RADS® ATLAS in connection with Your licensed use of Epics software during the term of Your license agreement with Epic. American College of Radiology shall retain title to, ownership and all intellectual property rights to BI-RADS® ATLAS and any modifications, corrections, enhancements, updates or other modifications, including custom modifications and any of its enhancements.
[***]
III. | RESTRICTIONS. |
A. | You may not copy BI-RADS® ATLAS, or sell, sublicense, rent, lease or transfer BI-RADS® ATLAS to any third party. |
B. | You may use BI-RADS® ATLAS only in conjunction with Your licensed use of Epics software. |
IV. | DISCLAIMER OF WARRANTIES / LIMITED DAMAGES. |
DISCLAIMER OF WARRANTY: BI-RADS® ATLAS IS PROVIDED TO YOU STRICTLY AS IS WITHOUT WARRANTY OF ANY KIND. NO WARRANTY OF ANY KIND IS BEING PROVIDED OR WILL BE PROVIDED TO YOU OR ANY THIRD PARTY. THE ENTIRE RISK AS TO THE USE OF BI-RADS® ATLAS IS HEREBY EXPRESSLY ASSUMED BY YOU. EPIC AND AMERICAN COLLEGE OF RADIOLOGY EACH HEREBY DISCLAIM ANY AND ALL WARRANTIES OF ANY KIND OR NATURE PERTAINING OR RELATING TO BI-RADS® ATLAS OR ANY PART THEREOF, WHETHER EXPRESS OR IMPLIED OR WRITTEN OR ORAL, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, ACCURACY, FITNESS FOR A PARTICULAR PURPOSE AND TITLE, AND ANY IMPLIED WARRANTY AGAINST INTERFERENCE WITH YOUR ENJOYMENT OF THE PROGRAM PROPERTY OR BI-RADS® ATLAS OR AGAINST INFRINGEMENT.
YOU ACKNOWLEDGE THAT NO EMPLOYEE OF EPIC OR ANY OTHER PARTY IS AUTHORIZED TO MAKE ANY REPRESENTATIONS OR WARRANTIES REGARDING THE BI-RADS® ATLAS.
DAMAGE LIMITATION: IN NO EVENT SHALL EPIC OR AMERICAN COLLEGE OF RADIOLOGY BE LIABLE FOR ANY LOST OR ANTICIPATED PROFITS, OR ANY INCIDENTAL, EXEMPLARY, SPECIAL, OR CONSEQUENTIAL DAMAGES RESULTING FROM THE USE OF BI-RADS® ATLAS, REGARDLESS OF WHETHER EPIC OR AMERICAN COLLEGE OF RADIOLOGY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
* | A registered trademark of American College of Radiology. All Rights Reserved. |
1
[***]
2
ILLUSTRATION ADDENDUM
The following provision applies to the use of the images from the Sourcebook of Medical Illustration that have been supplied by Epic with the Program Property (the Images).
1. | Grant of Rights. Epic grants to You a revocable, nonexclusive license to copy and display the Images, but only in connection with Your licensed use of Epics Program Property. You may not distribute the Images or copies of the Images in any way to any party that is not employed by You or that is not Your Affiliate under the terms of the Agreement, except that Your licensed healthcare professionals and those licensed healthcare professionals of Your Affiliates may distribute hard copies of the Images to their patients solely for the patients personal use. This license is revocable by Epic if Your license to use any Item of Epics Program Property with which You are using the Images is terminated for any reason or if You breach the terms of this Agreement. |
[***]
3. | NO WARRANTY. YOU UNDERSTAND THAT THE IMAGES ARE PROVIDED ON AN AS IS BASIS, WITHOUT ANY WARRANTY OF ANY KIND FROM EPIC OR ANY OTHER PARTY AND EPIC AND ALL AUTHORS, CREATORS, DISTRIBUTORS AND OTHERS ASSOCIATED IN ANY WAY WITH SUCH IMAGES HEREBY DISCLAIM ANY WARRANTIES, WHETHER EXPRESSED OR IMPLIED, WITH RESPECT THERETO, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OF MERCHANTABILITY, ACCURACY, FITNESS FOR A PARTICULAR PURPOSE AND TITLE, AND ANY IMPLIED WARRANTY AGAINST INTERFERENCE WITH YOUR ENJOYMENT OF THE PROGRAM PROPERTY OR THE IMAGES OR AGAINST INFRINGEMENT. YOU ACKNOWLEDGE THAT NO EMPLOYEE OF EPIC OR ANY OTHER PARTY IS AUTHORIZED TO MAKE ANY REPRESENTATIONS OR WARRANTY NOT IN THIS AGREEMENT. YOU HEREBY AGREE TO WAIVE ANY CLAIMS YOU MAY HAVE AGAINST EPIC OR ANY AUTHORS, CREATORS, DISTRIBUTORS OR OTHERS ASSOCIATED WITH SUCH IMAGES. |
4. | Acknowledgement. The Images are adapted by Epic Systems Corporation from images appearing in The Sourcebook of Medical Illustration, edited by Peter G. Cull MBE, OStJ, FMAA, Hon FIMI, RMIP, Professor Emeritus of Medical Art, St. Bartholomews and the Royal London School of Medicine and Dentistry, Queen Mary & Westfield College, University of London, UK. The work was compiled by staff artists under the direction of Professor Cull, among whom were Lois Hague, Andrew Bezear, Joanna Cameron, Wendy Proctor, Sandra Hill and Anne Clayton. Copyright in The Sourcebook of Medical Illustration is held by St. Bartholomews and the Royal London School of Medicine and Dentistry, Queen Mary and Westfield College. Used with permission. |
Miscellaneous Assessment Tool Collection (Third-Party) Addendum
The provisions in this Addendum apply to the license for the following items of third-party content:
1. | Elsevier Content, consisting of the following items: |
i. | Teasdale, et al. (1974). Assessment of Coma and Impaired Consciousness. Lancet, 304(7872), 81-84. |
ii. | Modified Glasgow Coma Scale for Infants and Children from Hazinski, MF: Nursing Care of the Critically Ill Child, 2nd ed., St. Louis, MO, Mosby Year Book; 1992. Reproduced with the permission of Elsevier Inc. All Rights Reserved. |
iii. | New Ballard Score, from Journal of Pediatrics, V119: 417-423, Ballard JL, et al: New Ballard Score © 1991 Mosby. Reproduced with the permission of Elsevier Inc. All Rights Reserved. |
iv. | Babson & Benda Fetal Infant Growth Chart from Journal of Pediatrics, V89(5): 814-820, Babson S.G. et al: Growth graphs for © 1976 Mosby. Reproduced with the permission of Elsevier Inc. All Rights Reserved. |
v. | Wong-Baker FACES Pain Rating Scale, From: Wong D.L., Hockenberry-Eaton M., Wilson D., Winkelstein M.L., Schwartz P.: Wongs Essentials of Pediatric Nursing, ed. 6, St. Louis, 2001, p. 1301 Copyrighted by Mosby, Inc. |
vi. | Pediatric Early Warning Score (PEWS) table from Journal of Critical Care. Vol 21, Issue 3: pp.271-278. Reproduced with the permission of Elsevier Inc. All Rights Reserved. |
2. | RAND Content, consisting of the following items: |
i. | 36-Item Short Form Health Survey, reproduced with permission from the RAND Corporation. Copyright © the RAND Corporation. RANDs permission to reproduce the survey is not an endorsement of the products, services, or other uses in which the survey appears or is applied. (Note: This item of content initially will be included only if You have licensed Epics MyChart Shared Patient Record.) |
ii. | RAND MOS 20-Item Short Form Health Survey (SF-20) is reproduced with permission from the RAND Corporation. Copyright © the RAND Corporation. RANDs permission to reproduce the survey is not an endorsement of the products, services, or other uses in which the survey appears or is applied. |
3. | Pfizer Content, consisting of the following items: |
i. | Patient Health Questionnaire (PHQ), Brief Patient Health Questionnaire (Brief PHQ), and Patient Health Questionnaire 9 (PHQ-9). Developed by Drs. Robert L. Spitzer, Janet B. W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer, Inc. No permission required to reproduce, translate, display, or distribute. |
ii. | Readiness to Quit Questionnaire copyright Pfizer Inc., 2009; used with permission. |
4. | Jensen D. et al.: LATCH: Breastfeeding Charting System, JOGNN, Jan/Feb 1994. |
5. | Inouye, S. et al. (1990). Clarifying Confusion: The Confusion Assessment Method. Annals of Internal Medicine, 113(12), 941-948. |
6. | The Braden Scale for Predicting Pressure Sore Risk. Copyright Barbara Braden and Nancy Bergstrom, 1988. Reprinted with permission. |
7. | Sleep State Values, from: Brazelton T.B. & Nugent, J.K. (1995). The Neonatal Behavioral Assessment Scale. MacKeith Press, London. |
8. | Aldrete Post-Anesthesia Recovery Score, reproduced with permission from its author, Dr. J.A. Aldrete. |
9. | Tinetti Assessment Tool for Balance and Gait, from: Tinetti, M.E. Performance-Oriented Assessment of Mobility Problems in Elderly Patients, Journal of the American Geriatric Society, 1986, 34:119-126. |
10. | Merkel, S., Voepel-Lewis T., Shayevitz, J. & Malviya, S. The FLACC: A Behavioral Scale for Scoring Postoperative Pain in Young Children. Pediatric Nursing, 1997, 23:293-297. © 2002, the Regents of the University of Michigan. |
11. | Greene, F.L., Page, D.L., Fleming, I.D., et al. AJCC Cancer Staging Manual, Sixth Edition. New York: Springer-Verlag, 2002. Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Sixth Edition (2002) published by Springer-Verlag New York, Inc. |
12. | Neonatal Infant Pain Scale, from Lawrence, J. et al (1993). The Development of a Tool to Assess Neonatal Pain. Neonatal Network, 12, 59-66 (Used with permission of Childrens Hospital of Eastern Ontario). |
1
13. | Sullivan, J.T., Sykora, K., Schneiderman, J., Naranjo, C.A., and Sellers, E.M. Assessment of Alcohol Withdrawal: The Revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). British Journal of Addiction 84:1353-1357, 1989. |
14. | Epworth Sleepiness Scale, © 1990-1997 M.W. Johns. Used under license. |
15. | Curley, M., Razmus, I., Roberts, K., & Wypij, D. Predicting Pressure Ulcer Risk in Pediatric Patients: The Braden Q Scale. Nursing Research, 52(1). 22-23. http://lww.com |
16. | Caprini, J.A., Thrombosis Risk Assessment as a Guide to Quality Patient Care, Dis Mon 2005; 51:70. Modified and incorporated with permission from J.A. Caprini, MD, Northwestern Feinberg School of Medicine. |
17. | Rosenbek, J., Robbins, J., Roecker, E., Coyle, J. & Wood, J. (1996). A Penetration-Aspiration Scale. Dysphagia, 11(2). 93-98. |
18. | Silverman, W.A., & Anderson, S.H., A Controlled Clinical Trial of Effects of Water Mist on Obstructive Respiratory Signs, Death Rate and Necropsy Findings Among Premature Infants. Pediatrics, Ja 1956; 17(1): 1-10. |
19. | Cox, J.L., Holden, J.M., and Sagovsky, R. (1987). Detection of Postnatal Depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 150:782-786. Users may reproduce the scale without further permission providing they respect copyright by quoting the names of the authors, the title and the source of the paper in all reproduced copies. |
20. | National Institutes of Health (NIH) Stroke Scale. National Institute of Neurological Disorders and Stroke, National Institutes of Health (2003). |
21. | NPASS:Neonatal Pain, Agitation & Sedation Scale, P. Hummel & M. Puchalski. Loyola University Chicago 2002. Used with permission from Pat Hummel, RNC, MA, NNP, PNP. |
22. | Warden, V., Hurley, A.C. & Volicer, L. Development and Psychometric Evaluation of the Pain Assessment in Advanced Dementia (PAINAD) Scale. Am Med Dir Assoc 2003; 4: 915. |
23. | Devlin J.W., Boleski G., et al. Motor Activity Assessment Scale: A Valid and Reliable Sedation Scale for Use with Mechanically Ventilated Patients in an Adult Surgical Intensive Care Unit. Crit Care Med. 1999; 27: 1271-1275 (Table 1, page 1276). |
24. | Ramsay Sedation Score, Ramsay M.A.E., Savege, T.M., et al. Controlled Sedation with Alphaxalone-Alphadolone. Br. Med J. 1974; ii: 66-659. |
25. | Edmonton Symptom Assessment System, from: Bruera, Juehn, N., Miller, M.J., Selmser, P., Macmillan, K. The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients. J. Palliat Care 1991; 7(2):6-9. |
26. | Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P. Toxicity and Response Criteria of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982. Provided by Eastern Cooperative Oncology Group. |
27. | Davidson, et al. (1974). REEDA: Evaluating Postpartum Healing. Journal of Nurse-Midwifery, 19, 6-8. (Table 1). |
28. | Bishop Score, from: Bishop, E.H., Pelvic Scoring for Elective Induction. Obstet Gynecol 1964; 24:266-8. |
29. | Finnegan, L.P., Kron, R.E., Connaughton, J.F., & Emich, J.P., A Scoring System for Evaluation and Treatment of the Neonatal Abstinence Syndrome: A New Clinical and Research Tool. In Basic and Therapeutic Aspects of Perinatal Pharmacology, Ed., Morselli, P.L., Garattini, S., & Sereni, F., New York: Raven Press 139155, 1975. |
30. | Palliative Performance Scale Version 2 (PPSv2). Copyright 2001 Victoria Hospice Society, Victoria BC, Canada. V8R 1J. |
31. | Morse Fall Risk Scale, from: Preventing Patient Falls by Janice M. Morse (2nd ed., Springer Publications, 2008). |
32. | 2008 Revised Canadian Triage and Acuity Scale Adult guidelines. Bullard, M.J., Unger, B., Spence, J., Grafstein, E., the CTAS National Working Group. Revisions to the Canadian Emergency Department Triage and Acuity Scale (CTAS) Adult Guidelines. CJEM 2008; 10:136-42. |
33. | MDS 3.0. Copyright 2011. InterRAI, may be freely used and distributed solely within the United States. Portions of the MDS 3.0 are under separate copyright protections; Pfizer Inc. holds the copyright for the PHQ-9 and the Annals of Internal Medicine holds the copyright for the CAM. Both Pfizer Inc. and the Annals of Internal Medicine have granted permission to freely use these instruments in association with the MDS 3.0. |
34. | Kline, N.E., Thom, B., Quashie, W., Brosnan, P. & Dowling, M. (2008). A Model of Care Delivery to Reduce Falls in a Major Cancer Center. Advances in Patient Safety: New Directions and Alternative Approaches. Volumes 1-4, AHRQ Publication Nos. 08-0034 (1-4). Agency for Healthcare Research and Quality, Rockville, MD. |
35. | U.S. Department of Veterans Affairs: VA National Center for Patient Safety Mental Health Environment of Care Checklist, 2010. For further information on patient safety visit the NCPS at www.patientsafety.gov. |
2
36. | Cummings, R. (2005). Cummings Pediatric Fall Assessment Scale. In V.R. Bowden & C.S. Greenberg, Pediatric Nursing Procedures, (2nd ed., p. 284). New York, NY: Wolters Kluwer Health/Lippincott Williams & Wilkins. |
37. | Project BOOST®. © Mark Williams MD, et al. Project Boost Mentoring Program, Society of Hospital Medicine, 2010. www.hospitalmedicine.org/BOOST. |
38. | The Development and Evaluation of a Disease-Specific Quality of Life Measurement Tool for Osteoarthritis of the Shoulder: The Western Ontario Osteoarthritis of the Shoulder Index. Osteoarthritis and Cartilage 9: 771-778, 2001. Used with permission by Fowler Kennedy Sport Medicine Clinic, University of Western Ontario. |
39. | MEDCIN Nomenclature (does not include nursing, diagnoses, interventions or actions), and MEDCIN Search, copyright Medicomp Systems, Inc., 14500 Avion Parkway, Suite 175, Chantily, VA 20151. |
40. | Pasero Opioid Sedation Scale copyright Chris Pasero, 1994. |
41. | Assume Pain Present, copyright Chris Pasero and Margo McCaffery, 1999. |
42. | Adult Non-Verbal Pain Score (ANVPS). © Strong Memorial Hospital, University of Rochester Medical Center, 2004. |
43. | Classification of Physical Status. ASA Physical Classification System, 2012. Reprinted with permission of the American Society of Anesthesiologists, 520 N. Northwest Highway, Park Ridge, Illinois 60068-2573. |
44. | Confusion Assessment Method for the ICU (CAM ICU), copyright © 2002, E. Wesley Ely, MD, MPH and Vanderbilt University, all rights reserved. |
45. | Posner, K., Brent, D., Lucas, C., Gould, M., Stanley, B., Brown, G., Fisher, P., Zelazny, J., Burke, A., Oquendo, M., & Mann J. (2008). The Research Foundation for Mental Hygiene, Inc. |
46. | Gavin, D.R., Ross, H.E., Skinner, H.A. (1989). Diagnostic Validity of the Drug Abuse Screening Test in the Assessment of DSM-III Drug Disorder. British Journal of Addiction, 84(3):301-307. |
47. | AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. Second Edition. Thomas F. Babor, John C. Higgins-Biddle, John B. Saunders, and Maristela G. Monteiro. Copyright © 2001 World Health Organization, Department of Mental Health and Substance Dependence. |
48. | Buckenmaier, C.C., Galloway, K.T., Polomano, R.C., McDuffie, M., Kwon, N. and Gallagher, R.M. (2013). Defense and Veterans Pain Rating Scale. Preliminary Validation of the Defense and Veterans Pain Rating Scale (DVPRS) in a Military Population. Pain Medicine, 14(1):110123. |
49. | Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M., Leirer, V.O. (1982-1983). Development and Validation of a Geriatric Depression Screening Scale: a Preliminary Report. J Psychiatr Res., 17(1):37-49. Published 1982. |
50. | Anderson, A.F., Irrgang, J.J., Kocher, M.S., Mann, B.J., Harrast, J.J. The International Knee Documentation Committee Subjective Knee Evaluation Form: Normative Data American Journal of Sports Medicine, 34(1): 8, copyright © 2006 by SAGE Publications. Reprinted by Permission of SAGE Publications. |
51. | Knee Injury and Osteoarthritis Outcome Score (KOOS). Developed by Ewa Roos, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark. Published 1998. |
52. | Knee Injury and Osteoarthritis Outcome Score- Physical Function Shortform (KOOS-PS). Developed by Ewa Roos, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark. Published 1998. |
53. | Brooks S.J., Krulewicz, S.P., Kutcher, S. (2003). The Kutcher Adolescent Depression Scale: Assessment of its Evaluative Properties over the Course of an 8-Week Pediatric Pharmacotherapy Trial. Journal of Child and Adolescent Psychopharmacology, 13(3):337-49. The KADS was developed by Dr. Stan Kutcher and is under copyright. |
54. | Length of Fetal Long Bones. Joanly, P., Romero, R., Published in Obstetrical Ultrasound by McGraw Hill 1984, p233. Used with Permission of Dr. Roberto Romero NICHD, NIH, DHHS. |
55. | Lund and Browder Chart for Estimating and Documenting the Severity and Extent of Burn Wounds in Adults and Children (revised 2008 Feb). In: eTG complete. Melbourne: Therapeutic Guidelines Limited; 2011 Nov. http://www.tg.org.au |
56. | Modified Early Warning System (MEWS). Cambridge, Massachusetts: Institute for Healthcare Improvement; 2011. Used with Permission of IHI. (Available at http://www.ihi.org/knowledge/Pages/ImprovementStories/EarlyWarningSystemsScorecardsThatSaveLives.aspx) |
57. | Mifflin, M.D., St Jeor, S.T., Hill, L.A., Scott, B.J., Daugherty, S.A., Koh, Y.O., A New Predictive Equation for Resting Energy Expenditure in Healthy Individuals. American Journal of Clinical Nutrition, 1990; 51(2):241-247. American Society for Nutrition. |
58. | Noonan Syndrome Boys Growth Chart. © 2007 Novo Nordisk Inc. |
3
59. | Frankenfield, D., Smith, J.S., Cooney, R.N., (2004). Validation of 2 Approaches to Predicting Resting Metabolic Rate in Critically Ill Patients. Journal of Parenteral and Enteral Nutrition, 28(4):6, copyright © 2004 by Sage Publications. Reprinted by Permission of SAGE Publications. |
60. | PROMIS Version 1.0 Measures. These measures are provided by the NIH and PROMIS Investigators. |
61. | Sessler, C.N., Gosnell, M., Grap, M.J., Brophy, G.T., ONeal, P.V., Keane K.A., et al. (2002). The Richmond Agitation-Sedation Scale: Validity and Reliability in Adult Intensive Care Patients. Am J Respir Crit Care Med, 166:1338-1344. |
62. | Radiological Society of North America (RSNA) Content, consisting of the following items: |
i. | Table 1: Hadlock, F.P., Harrist, R.B., Martinez-Poyer, J. In Utero Analysis of Fetal Growth: a Sonographic Weight Standard. Radiology 1991;181:129-133. |
ii. | Table 1: Hadlock, F.P., Harrist, R.B., Carpenter, R.J., et al. Sonographic Estimation of Fetal Weight. The Value of Femur Length in addition to Head and Abdomen Measurements. Radiology, 1984; 150:535-540. |
63. | SRS-22r. Asher, M.A., Lai, S.M., Glattes, R.C., Burton, D.C., Alanay, A., Bago, J. Refinement of the SRS-22 Health-Related Quality of Life Questionnaire Function Domain, Spine, 2006;31:593-7. Used with permission from Scoliosis Research Society. http://www.srs.org/professionals/SRS_outcomes/bibliography.pdf |
64. | Williams Syndrome Growth Chart. New Height, Weight and Head Circumference Charts for British Children with Williams Syndrome. N.D.T. Martin, W.R. Smith, T.J. Cole, M.A. Preece. Arch Dis Child, 2007; 92:598-601, copyright © Williams Syndrome Foundation. All rights are reserved. All enquiries should be made to the Williams Syndrome Foundation, 161 High Street, Tonbridge, Kent, England TN9 1BX, www.williams-syndrome.org.uk. 00 44 1732 365152. ***@***. |
65. | MAHC-10. Home Health Care Management and Practice. Sept 2012. Reproduced with permission of Missouri Alliance for Home Care. |
66. | Parkes, C.M. (1981). Evaluation of a Bereavement Service. Journal of Preventive Psychiatry, 1, 179-188. |
67. | Rollins, Jonathan D., Collins, Julianne S., Holden, Kenton R. (2010). United States Head Circumference Growth Reference Charts: Birth to 21 Years. Journal Of Pediatrics, 156(6), 907-912. |
68. | Predicted Normal Values for Measurements of the Fetus in Utero Growth Chart. Reprinted with permission of Anderson Publishing Ltd. From Hadock, et al. Applied Radiology 12:28, 1983 © Anderson Publishing Ltd. |
69. | Body Weight for Amputees- Scale found in Current Prospective on Assessment of Human Body Proportions of Relevance to Amputees, Linda Kautz Osterkamp, Journal Of The American Dietetic Association, February 1, 1995 Vol. 95(2):215-218. Reproduced with the permission of Elsevier Inc. All Rights Reserved. |
70. | Monoghan, Alan. Paediatric Early Warning Score. (PEWS). Detecting and Managing Deterioration in Children. Paediactric Nursing, 17, 32-35. |
71. | Makam et al. (2013). Identifying Patients with Diabetes and the Earliest Date of Diagnosis in Real Time: an Electronic Health Record Case-Finding Algorithm. BMC Medical Informatics and Decision Making 13:81. © 2013 Makam et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0). |
72. | Hester Davis Scale for Falls Risk Assessment Version 1.01 part of UAMS Invention Disclosure 2012-04. Hester, Amy, Davis, Dees. Assigned to the Board of Trustees of the University of Arkansas |
73. | Glasgow Coma Scale, Reprinted from The Lancet, Vol. 304, No. 7872, Teasdale et al, Assessment of Coma and Impaired Consciousness. 81-84, © 1974, with permission from Elsevier. |
74. | Meyer Risk of Spiritual Suffering Scale. Copyright © Hospice of the Bluegrass, 2312 Alexandria Drive, Lexington, KY 40504. For questions or feedback on the Meyer Risk of Spiritual Suffering Scale contact Bonnie Meyer at ***@***. |
75. | Andrete, J. Antonio. (1995). The Post Anesthesia Recovery Score Revisited. Journal of Anesthesia, 7(1), 3 pages. Reproduced with the permission of Elsevier Inc. All Rights Reserved. |
76. | EPIC-26, Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer. Urology. 56: 899-905, 2000. |
77. | ACR Indications and Scenarios Copyright American College of Radiology. Used with permission of American College of Radiology. |
78. | Cancer Outcomes and Services Dataset User Guide Version 2.1. National Cancer Intelligence Network. (2013) Open Government License: http://www.nationalarchives.gov.uk/doc/open-government-licence/version/2/ |
79. | Modified Bishops Score. American Journal of Obstetrics and Gynecology. 2004 Nov; 191(5), 1644-1648. Modified Bishops Score, Amer Jrl Ob Gyn. Reproduced with the permission of Elsevier Inc. All Rights Reserved. |
80. | AUA Symptoms Score. American Urological Association. |
4
81. | Van Walraven, C., Wong, J., Forster, A.J. (2012). LACE+ Index: Extension of a Validated Index to Predict Early Death or Urgent Readmission After Hospital Discharge using Administrative Data. Open Medicine, 6(3), 80-90. |
82. | ICCR Datasets. Copyright International Collaboration on Cancer Reporting. Used with permission of The Royal College of Pathologists of Australia. www.rcpa.edu.au//Library/Practising-pathology/ICCR/Cancer-Datasets |
83. | Data elements provided by the American Congress of Obstetricians & Gynecologists (ACOG). For full versions of the forms containing these data elements, please contact the ACOG directly. |
84. | Karnofsky, D.A., Burchenal, J.H. (1949). Karnofsky Performance Scale. The Clinical Evaluation of Chemotherapeutic Agents in Cancer. Evaluation of Chemotherapeutic Agents Pg. 196. In MacLeod CM (Ed), Columbia Univ Press. |
85. | Weissman, Meier. (2011). Identifying Patients in Need of a Palliative Care Assessment in the Hospital Setting a Consensus Report from the Center to Advance Palliative Care. Journal of Palliative Medicine, 14(1), 17-23. |
86. | EFPT Test. American Journal Occupational Therapy; 2008 Jul-Aug; 62(4):446-55. |
87. | Vernon, H., Mior, S. (1991). The Neck Disability Index: A Study of Reliability and Validity. Journal of Manipulative and Physiological Therapeutics, 14, 409-415. |
88. | Franck, L.S., Harris, S.K., Soetenga, D.J., Amling, J.K., & Curley, M.A.Q. (2008). The Withdrawal Assessment Tool Version 1 (WAT-1): An Assessment Instrument for Monitoring Opioid and Benzodiazepine Withdrawal Symptoms in Pediatric Patients. Pediatric Critical Care Medicine, 9(6), 573580. |
89. | Berg, K.O., Wood-Dauphinee, S.L., et al. (1992). Measuring Balance in the Elderly: Validation of an Instrument. Canadian Journal of Public Health, 83(2), 7-11. |
90. | Zimmerman, J., Kramer, A., McNair, D., Malila, F. (2006). Acute Physiology and Chronic Health Evaluation (APACHE) IV: Hospital Mortality Assessment for Todays Critically Ill Patients. Critical Care Medicine, 34(5), 1297- 1310. |
91. | Roland M.O., Morris R.W. (1983). A Study of the Natural History of Back Pain. Part 1: Development of a Reliable and Sensitive Measure of Disability in Low Back Pain. Spine, 8, 141-144. |
92. | Numeric Pain Intensity Scale. Acute Pain Management: Operative or Medical Procedures and Trauma, Clinical Practice Guideline No.1. AHCPR Publication No. 92-0032; 1992. Agency for Healthcare Research & Quality, Rockville, MD; pages 116-117. AHCPR is now Agency for Healthcare Research and Quality (AHRQ). |
93. | Ferreira, Flavio Lopes, Bota, Daliana Peres et al. (2001). Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients. JAMA, 286(14). Copyright © 2001 American Medical Association. All rights reserved. |
94. | Le Gall, Jean-Roger, Lemeshow, Stanley. (1983). A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study. JAM, 270 (24) Copyright © 1983 American Medical Association. All rights reserved. |
95. | Lip, Gregory Y.H., Nieuwlaat, Robby, Pisters, Ron, et. al. (2010). Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation. Chest. American College of Chest Physicians. 137(2). |
96. | National Cancer Institute. Common Terminology Criteria for Adverse Events v4.0. NCI, NIH, DHHS. May 29, 2009. NIH publication # 09-7473 The CTCAE is provided by the NCIs Cancer Therapy Evaluation Program (CTEP), a program within the NCIs Division of Cancer Treatment and Diagnosis (DCTD). |
97. | Dawber, T.R., Meadors, G.F., Moore, F.E., Jr. (1951). Epidemiological Approaches to Heart Disease: the Framingham Study. Am J Public Health, 41(3), 279-286. Used with Permission by Framingham Heart Study, a project of the National Heart, Lung, and Blood Institute and Boston University. |
98. | Olsen Growth Charts. Reproduced with permission from Pediatrics Vol. 125(2), Page 214, Copyright © 2010 by the AAP. New Intrauterine Growth Curves Based on United States Data. http://pediatrics.aappublications.org/content/125/2/e214.abstract |
99. | Charlson, M.E., Pompei, P., Ales K.L., MacKenzie, C.R. (1987). A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation. Journal of Chronic Diseases, 40(5). Reproduced with the permission of Elsevier Inc. All Rights Reserved. |
100. | Knaus, W., Draper, E., Wagner, D., Zimmerman, J. (1985). APACHE II: A Severity of Disease Classification System. Critical Care Medicine, 13(10), 818-829. |
101. | Stop Bang Questionnaire. Stop Questionnaire: A Tool to Screen Patients for Obstructive Sleep Apnea. Chung et al. Anesthesiology. 2008. Vol. 108(5) 812-821. |
102. | Choosing Wisely, Used with permission of the ABIM Foundation. 2014. www.choosingwisely.org |
103. | Sheldrick, R.C., Perrin, E.C. (2009). Surveillance of Childrens Behavior and Development: Practical Solutions for Primary Care. Journal of Developmental and Behavioral Pediatrics, 30, 151-153. |
5
104. | NSI DETERMINE Checklist. Nutrition Screening Initiative. Report of Nutrition Screening Initative. Toward a Common View. Washington, DC; Nutrition Screening Initiative; published 1991. |
105. | Kemper A.R., Mahle W.T., Martin G.R., Cooley W.C., Kumar P., Morrow W.R., Kelm K., Pearson G.D., Glidewell J., Grosse S.D., Lloyd-Puryear M., Howell R.R. (2011). Strategies for Implementing Screening for Critical Congenital Heart Disease. Pediatrics,128, 1-8. |
106. | Fenton, T.R., Kim J.H. A Systematic Review and Meta-Analysis to Revise the Fenton Growth Chart for Preterm Infants. BMC Pedistr. 2013;13:59. |
107. | Academy of Nutrition and Dietetics. Nutrition Terminology Reference Manual (eNCPT): Dietetics Language for Nutrition Care. http://ncpt.webauthor.com |
108. | FIGO Staging for Carcinoma of the Vulva, Cervix and Corpus Uteri. International Journal of Gynecology and Obstetrics. 2014. 125(3), 97-98. Reproduced with the permission of Elsevier Inc. All Rights Reserved. |
109. | Cappuccio, F.P., Rink, E., Perkins-Porras, L., et al. (2003). Estimation of Fruit and Vegetable Intake Using a Two-Item Dietary Questionnaire: A Potential Tool for Primary Health Care Workers. Nutrition, Metabolism and Cardiovascular Diseases, 13(1), 12-9. |
110. | Windsor, John. Nutrition in Acute Pancreatitis: Moving Full Circle or Moving Forward? American Gastroenterological Association. AGA-Perspectives. July 2014. http://www.gastro.org/journals-publications/aga-perspectives/junejuly-2014/nutrition-in-acute-pancreatitis-moving-full-circle-or-moving-forward |
111. | Family History Screen is licensed by Ashton-Prolla, et al, under the Creative commons attribution license 4.0. |
112. | Any additional third-party tool content items that Epic subsequently provides You notice have been added free of charge to its Miscellaneous Assessment Tool Collection. |
I. | DEFINITIONS. |
Third-Party Content means the items of third-party scales, assessment and documentation tool content listed above. Third-Party Content includes all updates and additions and revisions to the Third-Party Content that are provided by Epic to You.
II. | LICENSE. |
A. General. Subject to the restrictions in the Agreement and this Addendum, You are granted a non-exclusive license to use the Third-Party Content in connection with Your use of the Epic Program Property set forth on Exhibit 1(a) to the Agreement (or, if applicable, in the amendment to the Agreement adding this Addendum). These items are licensed to You for Your convenience at no charge to You. Epic reserves the right to terminate Your license to one or more of these items, at Epics sole discretion and without prior notice to You.
B. Ownership. This is a license and not a transfer of ownership in any of the Third-Party Content. The respective authors or copyright holders for the Third Party Content retain all title and ownership rights to the Third-Party Content and all intellectual property rights relating to the Third-Party Content. You shall not alter or remove from the Program Property any attributions or copyright notice information pertaining to the Third-Party Content.
C. Restrictions. All of the limitations and restrictions on access or use of the Program Property under the Agreement shall also apply to the Third-Party Content. In addition, You will not use the Third-Party Content in any closed-loop system that provides medical care without human intervention. You also agree to represent and use the Third-Party Content within the Program Property as received from or demonstrated by Epic, without alteration, addition or modification. The Third-Party Content requires You to exercise independent, clinical judgment in the delivery of patient care.
D. Additional Information and Restrictions Specific to Certain Content Items. The following additional restrictions apply with regard to the specific items of Third-Party Content:
a. | Braden Scale: |
i. | You agree not to abridge or change the wording or scoring of the tool; |
ii. | You will obtain the authors permission before adding additional evaluation characteristics or scoring criteria to the tool; |
iii. | If You use the tool in paper form, You will: (a) do so without abridging or changing the wording or scoring of the tool, and (b) provide the full name of the tool (The Braden Scale for Predicting Pressure Sore Risk), and include the following notice on such paper version: Copyright. Barbara Braden and Nancy Bergstrom, 1988. Reprinted with Permission. All rights reserved.) |
6
b. | FLACC Pain Assessment Tool: |
i. | You agree to use the capitalized style of FLACC when identifying the title of the scale; |
ii. | You agree not to make changes to, additions to, or deletions from the coding for each category, or to/from the category names and defining characteristics; |
iii. | You agree to acknowledge the copyright with © 2002, the Regents of the University of Michigan and include the following when printing the FLACC on documentation records, etc.: Printed with permission © 2002, The Regents of the University of Michigan. |
c. | RAND 36-Item Short Form Health Survey: |
i. | Changes to the Health Survey may be made without the written permission of RAND. However, all such changes shall be clearly identified as having been made by the recipient. |
ii. | The Health Survey is provided in English. You accept full responsibility, and agree to indemnify and hold RAND harmless, for the accuracy of any translations of the Health survey into another language and for any errors, omissions, misinterpretations or consequences thereof. |
d. | Epworth Sleepiness Scale: |
i. | The English version of the Epworth Sleepiness Scale shall not be changed without the written permission of MW Johns. |
e. | Palliative Performance Scale Version 2 (PPSv2). |
i. | You agree not to alter the PPSv2, or use it in any way other than as intended and described in the Instructions for Use and Definition of Terms that have been provided by the Victoria Hospice Society and that are made accessible to You with the tool. |
f. | The Kutcher Adolescent Depression Scale |
i. | Individuals or organizations wishing to use the KADS outside of this application can contact Dr. Kutcher for written permission at: ***@***. More information about KADS and other supporting materials can be found at: www.teenmentalhealth.org. |
g. | Morse Fall Risk Scale: |
i. | The author requires that instructions for training be included with the tool; You therefore agree that You will not remove the link to online training that is embedded within the tool. |
ii. | The author recommends that organizations using this tool should have a copy of the book Preventing Patient Falls by Janice M. Morse (2nd ed., Springer Publications, 2008) available on each unit so that nurses can refer to fall prevention strategies, understand how the program works and know how to calibrate the scale. |
iii. | The author recommends using 45 as the high risk cutoff score, and she strongly recommends that all of the item scores are recorded, as well as the total score, so that as a patients scores increase or decrease, these scores can be used to monitor improvements or decline in the patients fall risk. |
h. | Patient Health Questionnaire, Brief Patient Health Questionnaire and Patient Health Questionnaire 9. |
i. | You will not translate the PHQ, PHQ-9 or any parts of the PHQ or PHQ-9 without first seeking permission from Pfizer. |
ii. | You will not modify or otherwise adapt the PHQ or PHQ-9 without permission, except: |
i. | only question 9 of the PHQ-9 (Thought that you would be better off dead or of hurting yourself in some way) can be eliminated, if so desired. |
ii. | the first two questions of the PHQ-9 (Questions 1&2), sometimes referred to as the PHQ-2, can be used without the remaining seven questions. |
iii. | You will not sell or incorporate the PHQ or PHQ-9 into materials that could be sold. |
iii. | You will include Pfizers copyright ownership statement and authors names on all copies of the PHQ and PHQ-9 they appear in the item list above (Item 32) |
i. | PROMIS Version 1.0 Measures. |
i. | You agree that You will not modify the PROMIS Measures or any parts of the PROMIS Measures without first obtaining permission from the NIH PROMIS Project Officer and PROMIS investigators. PROMIS is a registered trademark of the U.S. Department of Health and Human Services and may not be used without permission. |
7
j. | MAHC-10 |
i. | The fall risk assessment tool used for the validation research was the MAHC-10. The MAHC-10 consists of the required ten core elements, initial instructions, scoring mechanism and threshold for risk, all of which may not be altered or changed in any way. |
ii. | The word MAHC-10 must remain on the form or be embedded with the tool. |
iii. | Credit must be given to the Missouri Alliance for Home Care. |
k. | MEDCIN Nomenclature and MEDCIN Search |
i. | IN NO EVENT WILL MEDICOMP SYSTEMS, INC., BE LIABLE FOR ANY CONSEQUENTIAL, INCIDENTIAL, OR DIRECT DAMAGES, INCLUDING WITHOUT LIMITATION, ANY LOSS OF DATA, LOSS OF PROFITS, OR LOST SAVINGS, ARISING OUT OF USE OF OR INABILITY TO USE THE LICENSED PRODUCTS OR DOCUMENTATION, EVEN IF MEDICOMP SYSTEMS, INC., HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, OR FOR ANY CLAIM BY ANY THIRD PARTY. IN NO EVENT SHALL MEDICOMP SYSTEMS, INC. BE LIABLE FOR ANY DAMAGES. |
l. | Family History Screen |
i. | Epic has modified the original measure to work with the Epic software, without the input or approval of the authors. You may share and copy the HARK scale provided that you follow the license requirements of the Creative Commons Attribution license 4.0, located at the time of this writing at http://creativecommons.org/publicdomain/zero/1.0/ |
III. | WARRANTY DISCLAIMER |
THE THIRD-PARTY CONTENT IS PROVIDED AS IS AND WITHOUT WARRANTY OF ANY KIND. ANY AND ALL WARRANTIES, WHETHER EXPRESSED OR IMPLIED, ARE HEREBY DISCLAIMED, INCLUDING WARRANTIES OF MERCHANTABILITY, ACCURACY, FITNESS FOR A PARTICULAR PURPOSE AND TITLE, AND ANY IMPLIED WARRANTY AGAINST INTERFERENCE WITH YOUR ENJOYMENT OF THE PROGRAM PROPERTY OR AGAINST INFRINGEMENT. YOU ACKNOWLEDGE THAT NO EMPLOYEE OF EPIC OR ITS SUPPLIERS OR ANY OTHER PARTY IS AUTHORIZED TO MAKE ANY REPRESENTATIONS OR WARRANTY RELATING TO THE CONTENT THAT IS NOT IN THE AGREEMENT OR THIS ADDENDUM.
IV. | LIMITATIONS OF LIABILITY. |
A. General Limitations in Agreement. In addition to any other limitations of liability in this Addendum, the limitations of Epics liability that apply to the Program Property, including without limitation those under Section 10 (Limitations of Liability) of the Agreement, shall also apply to limit Epics and its suppliers liability with respect to the Third-Party Content.
B. Specific Limitations for Third-Party Content. For any claim relating to the Third-Party Content or services relating thereto, Epics and its suppliers cumulative liability to You shall not exceed the actual, direct damages incurred by You and shall not exceed a maximum of two hundred dollars ($200).
V. | CONFIDENTIALITY. |
You agree to keep the Third-Party Content, as represented within the Program Property confidential in the same manner that You have agreed to keep the Epic Program Property confidential.
[***]
8
[***]
VII. | NOTICE. |
Unless otherwise indicated by Your completion of the requested information below, notices of additional third-party tool content items added free of charge to the Miscellaneous Assessment Tool Collection will be sent to the same address to which invoices are sent as provided in the Agreement. If You prefer to have such notices sent to a different person in Your organization, please indicate that by providing the appropriate contact information in the space provided below:
Name/Title: |
| |||
Address: |
| |||
| ||||
| ||||
E-mail: |
| |||
Phone: |
|
If at any time You would like to change this contact information and/or designate a new recipient for such notices within Your organization, You may do so by sending an email with the new contact information to ***@***.
9
ACADEMY OF NUTRITION AND DIETETICS ADDENDUM
The following provisions apply to the license to the Academy Terminology licensed under the Agreement.
I. | DEFINITIONS. |
Academy means the Academy of Nutrition and Dietetics.
Publication means the Academys publication, International Dietetics and Nutrition Terminology (IDNT) Reference Manual: Standard Language for the Nutrition Care Process, Second Edition.
Academy Terminology means certain standardized language, vocabulary, terminology and codes developed by the Academy for use in nutrition assessment, nutrition diagnosis, nutrition intervention, and nutrition monitoring and evaluation and contained in the Publication. Academy Terminology includes all updates and additions and revisions to such standardized language, vocabulary, terminology and codes that are provided to You by Epic.
II. | LICENSE. |
Subject to the restrictions in the Agreement and this Addendum, You are granted a non-exclusive, non-transferable license to use the Academy Terminology in connection with Your licensed use of the Epic Program Property set forth on Exhibit 1(a) to the Agreement (or, if applicable, in the amendment to the Agreement adding this Addendum) during the term of the Agreement. The Academy shall retain title to, ownership of and all other intellectual property rights in the Academy Terminology. You shall not alter or remove from the Program Property any attributions or copyright notice information pertaining to the Academy Terminology.
[***]
III. | RESTRICTIONS. |
A. | You may use the Academy Terminology only in conjunction with Your licensed use of the Epic Program Property. |
B. | You may not copy the Academy Terminology or sell, sublicense, rent, lease or transfer the Academy Terminology to any third party. |
C. | You may not make any changes or modifications to the Academy Terminology. |
IV. | DELETION AND CORRECTION OF LICENSED MATERIALS. |
If the Academy requests that Epic delete or correct any portion of the Academy Terminology because such Academy Terminology contains material errors or requires updating, then Epic may, or may require You to, delete or correct such Academy Terminology, or any references to such Academy Terminology, in Your possession as soon as reasonably possible.
V. | DISCLAIMER OF WARRANTY. |
DISCLAIMER OF WARRANTY: THE ACADEMY TERMINOLOGY (INCLUDING WITHOUT LIMITATION ANY DOCUMENTATION RELATED TO THE ACADEMY TERMINOLOGY) IS BEING PROVIDED AND IN EACH CASE SHALL BE PROVIDED TO YOU STRICTLY AS IS WITHOUT WARRANTY OF ANY KIND. NO WARRANTY OF ANY KIND IS BEING PROVIDED OR WILL BE PROVIDED TO YOU OR ANY THIRD PARTY. THE ENTIRE RISK AS TO THE USE OF THE ACADEMY TERMINOLOGY IS HEREBY EXPRESSLY ASSUMED BY YOU. EPIC AND THE ACADEMY EACH HEREBY DISCLAIM ANY AND ALL WARRANTIES OF ANY KIND OR NATURE PERTAINING OR RELATING TO THE ACADEMY TERMINOLOGY OR ANY PART THEREOF, WHETHER EXPRESS OR IMPLIED OR WRITTEN OR ORAL, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, ACCURACY, FITNESS FOR A PARTICULAR PURPOSE AND TITLE, AND ANY IMPLIED WARRANTY AGAINST INTERFERENCE, YOUR ENJOYMENT OF THE PROGRAM PROPERTY OR THE ACADEMY TERMINOLOGY OR AGAINST INFRINGEMENT.
1
YOU ACKNOWLEDGE THAT NO EMPLOYEE OF EPIC OR ANY OTHER PARTY IS AUTHORIZED TO MAKE ANY REPRESENTATIONS OR WARRANTIES REGARDING THE ACADEMY TERMINOLOGY.
VI. | LIMITATIONS OF LIABILITY. |
IN NO EVENT SHALL EPIC OR THE ACADEMY BE LIABLE FOR ANY LOST OR ANTICIPATED PROFITS, OR ANY INDIRECT, SPECIAL, INCIDENTAL, EXEMPLARY, PUNITIVE, SPECIAL, OR CONSEQUENTIAL DAMAGES RESULTING FROM THE USE OF OR INABILITY TO USE THE ACADEMY TERMINOLOGY, REGARDLESS OF WHETHER EPIC OR THE ACADEMY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
A. General Limitations in Agreement. In addition to any other limitations of liability in this Addendum, the limitations of Epics liability that apply to the Program Property shall also apply to limit Epics and the Academys liability with respect to the Academy Terminology.
B. Specific Limitations for Academy Terminology. For any claim relating to the Academy Terminology or services relating thereto, Epics and the Academys cumulative liability to You shall not exceed the actual, direct damages incurred by You and shall not exceed a maximum of two hundred dollars ($200).
[***]
2